<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="1.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Pharmacol.</journal-id>
<journal-title-group>
<journal-title>Frontiers in Pharmacology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Pharmacol.</abbrev-journal-title>
</journal-title-group>
<issn pub-type="epub">1663-9812</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">1729572</article-id>
<article-id pub-id-type="doi">10.3389/fphar.2025.1729572</article-id>
<article-version article-version-type="Version of Record" vocab="NISO-RP-8-2008"/>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Original Research</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Wound healing and photodynamic potential of <italic>Adiantum capillus-veneris</italic> L. (Pteridaceae): an evaluation of the cellular effects and molecular insights</article-title>
<alt-title alt-title-type="left-running-head">Mou et al.</alt-title>
<alt-title alt-title-type="right-running-head">
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fphar.2025.1729572">10.3389/fphar.2025.1729572</ext-link>
</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Mou</surname>
<given-names>Linru</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1489149"/>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing - original draft</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &#x26; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/">Writing - review and editing</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal Analysis</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Software" vocab-term-identifier="https://credit.niso.org/contributor-roles/software/">Software</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Visualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/visualization/">Visualization</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Jalil</surname>
<given-names>Banaz</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1057641"/>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &#x26; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/">Writing - review and editing</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Scotti</surname>
<given-names>Francesca</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/519253"/>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &#x26; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/">Writing - review and editing</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lane</surname>
<given-names>Majella E.</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &#x26; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/">Writing - review and editing</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Fiebich</surname>
<given-names>Bernd L.</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/20275"/>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &#x26; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/">Writing - review and editing</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sun</surname>
<given-names>Lu</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &#x26; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/">Writing - review and editing</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Maake</surname>
<given-names>Caroline</given-names>
</name>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/961029"/>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &#x26; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/">Writing - review and editing</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Funding acquisition" vocab-term-identifier="https://credit.niso.org/contributor-roles/funding acquisition/">Funding acquisition</role>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Heinrich</surname>
<given-names>Michael</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff6">
<sup>6</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/15167"/>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &#x26; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/">Writing - review and editing</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Funding acquisition" vocab-term-identifier="https://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role>
</contrib>
</contrib-group>
<aff id="aff1">
<label>1</label>
<institution>Pharmacognosy and Phytotherapy, UCL School of Pharmacy, University College London</institution>, <city>London</city>, <country country="GB">United Kingdom</country>
</aff>
<aff id="aff2">
<label>2</label>
<institution>Department of Pharmaceutics, UCL School of Pharmacy, University College London</institution>, <city>London</city>, <country country="GB">United Kingdom</country>
</aff>
<aff id="aff3">
<label>3</label>
<institution>Neurochemistry and Neuroimmunology Research Group, Department of Psychiatry and Psychotherapy, Medical Center, Faculty of Medicine, University of Freiburg</institution>, <city>Freiburg</city>, <country country="DE">Germany</country>
</aff>
<aff id="aff4">
<label>4</label>
<institution>Departmental of Clinical Laboratory Center, Beijing Children&#x2019;s Hospital, Capital Medical University, National Center for Children&#x2019;s Health</institution>, <city>Beijing</city>, <country country="CN">China</country>
</aff>
<aff id="aff5">
<label>5</label>
<institution>Institute of Anatomy, University of Zurich</institution>, <city>Zurich</city>, <country country="CH">Switzerland</country>
</aff>
<aff id="aff6">
<label>6</label>
<institution>Department of Pharmaceutical Sciences and Chinese Medicine Resources, Chinese Medicine Research Center, College of Chinese Medicine, China Medical University</institution>, <city>Taichung</city>, <country country="TW">Taiwan</country>
</aff>
<author-notes>
<corresp id="c001">
<label>&#x2a;</label>Correspondence: Michael Heinrich, <email xlink:href="mailto:m.heinrich@ucl.ac.uk">m.heinrich@ucl.ac.uk</email>
</corresp>
</author-notes>
<pub-date publication-format="electronic" date-type="pub" iso-8601-date="2026-01-05">
<day>05</day>
<month>01</month>
<year>2026</year>
</pub-date>
<pub-date publication-format="electronic" date-type="collection">
<year>2025</year>
</pub-date>
<volume>16</volume>
<elocation-id>1729572</elocation-id>
<history>
<date date-type="received">
<day>21</day>
<month>10</month>
<year>2025</year>
</date>
<date date-type="rev-recd">
<day>20</day>
<month>11</month>
<year>2025</year>
</date>
<date date-type="accepted">
<day>25</day>
<month>11</month>
<year>2025</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2026 Mou, Jalil, Scotti, Lane, Fiebich, Sun, Maake and Heinrich.</copyright-statement>
<copyright-year>2026</copyright-year>
<copyright-holder>Mou, Jalil, Scotti, Lane, Fiebich, Sun, Maake and Heinrich</copyright-holder>
<license>
<ali:license_ref start_date="2026-01-05">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
<license-p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License (CC BY)</ext-link>. The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<abstract>
<sec>
<title>Introduction</title>
<p>Chronic and infected wounds represent a persistent global health burden. Medicinal plants offer a promising source of wound-healing agents due to their multitarget activities, long history of traditional use, and accessibility. <italic>Adiantum capillus-veneris</italic> L. (ACV), traditionally used to treat a range of ailments, such as respiratory, urinary, and skin disorders, was investigated for its <italic>in vitro</italic> wound-healing potential following methanol extraction.</p>
</sec>
<sec>
<title>Methods</title>
<p>We evaluated the effects of methanol extracts of ACV (ACVM) on cell proliferation, migration and antioxidative capacity in human keratinocytes (HaCaT), and anti-inflammatory activity in RAW 264.7 cells. We also explored its combination with visible light phototherapy.</p>
</sec>
<sec>
<title>Results</title>
<p>Chemical profiling via HPTLC analysis, UV/Vis spectrophotometry and HPLC analysis, together confirmed that ACVM contained more metabolites than other extracts, yielding five visible-light absorption peaks and identifying rutin and chlorogenic acid as major metabolites. At &#x2264;100 &#x03BC;g/mL, ACVM was non-toxic to HaCaT cells in the absence of visible light. However, phototoxicity was evident at 200 &#x03BC;g/mL. ACVM (50 &#x03BC;g/mL) significantly promoted HaCaT migration, with a further enhancement upon exposure to light. ACVM also suppressed H<sub>2</sub>O<sub>2</sub>-induced ROS generation in a dose-dependent manner (&#x2264;50 &#x03BC;g/mL), while light exerted a bidirectional modulatory effect. Additionally, ACVM markedly inhibited LPS-induced secretion of CXCL2, CCL2, CXCL10, TNF-&#x03B1;, and IL-6 in RAW 264.7 macrophages, with effects evident at concentrations as low as 0.1 &#x03BC;g/mL.</p>
</sec>
<sec>
<title>Discussion</title>
<p>These findings suggest that ACVM, particularly in combination with light-assisted therapy, shows promise for accelerating wound healing.</p>
</sec>
</abstract>
<kwd-group>
<kwd>traditional medicinal plants</kwd>
<kwd>
<italic>Adiantum capillus-veneris L.</italic>
</kwd>
<kwd>wound healing</kwd>
<kwd>skin</kwd>
<kwd>dermatology</kwd>
<kwd>photodynamic therapy (PDT)</kwd>
<kwd>HaCaT</kwd>
</kwd-group>
<funding-group>
<funding-statement>The authors declare that financial support was received for the research and/or publication of this article. This work was partially supported by a grant from the VELUX STIFTUNG, supporting the work of BJ and FS, but not the first author&#x2019;s PhD.</funding-statement>
</funding-group>
<counts>
<fig-count count="9"/>
<table-count count="3"/>
<equation-count count="2"/>
<ref-count count="69"/>
<page-count count="16"/>
</counts>
<custom-meta-group>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Ethnopharmacology</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec sec-type="intro" id="s1">
<label>1</label>
<title>Introduction</title>
<p>Wounds are defined as any disruption in the integrity of the skin, and typically progress through the overlapping phases of haemostasis, inflammation, proliferation and remodeling (<xref ref-type="bibr" rid="B13">Ennis and Hill, 2016</xref>; <xref ref-type="bibr" rid="B65">Yazarlu et al., 2021</xref>). Disturbances caused by systematic disease or infection may impair these processes, resulting in delayed healing, chronic wounds or excessive scarring (<xref ref-type="bibr" rid="B57">Tabriz and Douroumis, 2022</xref>). The clinical and economic burden is considerable, particularly in regions with limited access to biomedical treatments, where traditional medicinal plants remain an essential component of primary healthcare. In 2018, the global cost of wound care was estimated at USD 18.4 billion, with projections reaching USD 25.04 billion by 2026, driven by an annual growth rate of 3.9% (<xref ref-type="bibr" rid="B39">Monika et al., 2022</xref>). In response, international health bodies (WHO) have increasingly emphasized the need for scientific evidence to support the safe and effective use of traditional medicines (<xref ref-type="bibr" rid="B20">Hoenders et al., 2024</xref>; <xref ref-type="bibr" rid="B64">World Health Organization, 2025</xref>).</p>
<p>
<italic>Adiantum capillus-veneris</italic> L. (Pteridaceae) (ACV) is a widely distributed fern used in various traditional medical systems and valued for treating internal disorders as well as skin conditions, including wounds (<xref ref-type="bibr" rid="B4">Ansari and Ekhlasi-Kazaj, 2012</xref>; <xref ref-type="bibr" rid="B46">Qadir et al., 2025</xref>). Phytochemical studies report terpenoids, flavonoids and other phenolics as major constituents, and may account for its reported antimicrobial, antioxidant and anti-inflammatory activities (<xref ref-type="bibr" rid="B12">Dehdari and Hajimehdipoor, 2018</xref>; <xref ref-type="bibr" rid="B48">Rastogi et al., 2018</xref>; <xref ref-type="bibr" rid="B22">Jaafer et al., 2025</xref>). Compounds such as chlorogenic acid and rutin, which are abundant in ACV, exhibit well-established wound-healing, anti-inflammatory and antioxidant properties (<xref ref-type="bibr" rid="B45">Patel and Patel, 2019</xref>; <xref ref-type="bibr" rid="B41">Nguyen et al., 2024</xref>). Although their classification as pan-assay interfering substances (PAINS) necessitates cautious interpretation of <italic>in vitro</italic> data (<xref ref-type="bibr" rid="B18">Heinrich et al., 2020</xref>; <xref ref-type="bibr" rid="B19">Heinrich et al., 2022</xref>).</p>
<p>Despite its ethnomedicinal relevance, the wound-healing effects of ACV have been only partially explored. Aqueous extracts enhanced fibroblast survival under oxidative stress, stimulated endothelial tube formation and showed low irritation potential in the chorion allantois membrane (CAM) model (<xref ref-type="bibr" rid="B42">Nilforoushzadeh et al., 2014</xref>). Methanolic extracts have been shown to increase Transforming Growth Factor Beta 1 (Tgf&#x3b2;1) and Vascular Endothelial Growth Factor A (Vegf-A) gene expression in fibroblasts (<xref ref-type="bibr" rid="B40">Negahdari et al., 2017</xref>), and ethanolic extracts demonstrated antioxidant activity in DPPH, ABTS and FRAP free radical scavenging models (<xref ref-type="bibr" rid="B43">Osman Mahmud et al., 2023</xref>).</p>
<p>
<italic>In vivo</italic>, an ACV-based formulation also including an extract from aloe and myrrha accelerates full-thickness wound closure in male Wistar rats, downregulating Mmp9 and modulating Tgfb1, Mmp3, IL-6, and TNF-&#x3b1; expression in wound tissue (<xref ref-type="bibr" rid="B14">Galehdari et al., 2016</xref>). ACV flavonoids mitigated CCl<sub>4</sub>-induced hepatic oxidative damage in mice by lowering MDA and restoring SOD, CAT and GSH levels (<xref ref-type="bibr" rid="B25">Jiang et al., 2011</xref>). Ethanolic ACV extracts also produced anticonvulsant and analgesic effects in mice, verified in pentylenetetrazole, maximal electroshock, hot-plate and tail-immersion tests (<xref ref-type="bibr" rid="B23">Jain et al., 2014</xref>). The 50% ethanolic extract of ACV demonstrated anti-inflammatory effects in a carbendazim-induced hepatotoxicity model in rats by suppressing NF-&#x3ba;B activation and reducing TNF-&#x3b1; and IL-6 levels (<xref ref-type="bibr" rid="B53">Seif et al., 2023</xref>).</p>
<p>However, evidence regarding ACV&#x2019;s effects on keratinocytes that play a central role in wound healing is limited. The only study involving HaCaT cells assessed antibacterial activity and evaluated cytotoxicity at a single concentration, without a full concentration&#x2013;response profile or detailed statistical analysis (<xref ref-type="bibr" rid="B28">Khan et al., 2018</xref>). Importantly, no study has considered whether phytochemicals in ACV may exert light-dependent biological effects.</p>
<p>Photosensitizers can absorb photons of a specific wavelength, resulting in excitation. In the presence of oxygen, such light-activated photosensitizers generate singlet oxygen and/or Reactive Oxygen Species (ROS), which may act as mediators of various downstream biological effects (<xref ref-type="bibr" rid="B62">Wang et al., 2021</xref>) (see a detailed schematic illustration of the Photodynamic therapy (PDT) mechanism in the <xref ref-type="sec" rid="s13">Supplementary Figure S1</xref>).</p>
<p>In clinical practice, while high ROS production underpins PDT for antimicrobial or anticancer applications (<xref ref-type="bibr" rid="B44">Papa et al., 2025</xref>), low levels of ROS generated under mild illumination can promote repair-related processes (<xref ref-type="bibr" rid="B60">Vallejo et al., 2020</xref>). Such low-dose photodynamic effects have been shown to enhance fibroblast and epidermal stem cell migration, support angiogenesis, regulate inflammation, and improve wound closure <italic>in vitro</italic>, <italic>in vivo</italic>, and in clinical settings (<xref ref-type="bibr" rid="B60">Vallejo et al., 2020</xref>; <xref ref-type="bibr" rid="B52">Scotti et al., 2021</xref>; <xref ref-type="bibr" rid="B69">Zhang et al., 2023</xref>; <xref ref-type="bibr" rid="B38">Mikzi&#x144;ski et al., 2025</xref>).</p>
<p>We here provide a comprehensive study that aims to (i) further extend the scientific knowledge underlying wound-healing effects of methanolic ACV extracts (ACVM), including its effects on human keratinocyte migration and proliferation, as well as its antioxidative and anti-inflammatory activities, and (ii) evaluate for the first time a possible impact of light-induced effects on these processes.</p>
<p>Our findings strengthen the scientific understanding of a widely used ethnomedicinal species and provide insights relevant to the development of safe, evidence-based phytotherapeutic strategies for wound care, particularly in settings with limited access to medical interventions (e.g., medicines).</p>
</sec>
<sec sec-type="materials|methods" id="s2">
<label>2</label>
<title>Materials and methods</title>
<sec id="s2-1">
<label>2.1</label>
<title>Procurement of plant materials and chemicals</title>
<p>Authenticated dried ACV stems and leaves were sourced from Guqingtang Pharmacy (Anhui, China), with plant material harvested in August 2022 in Bozhou, Anhui Province (approximately 33.877&#xb0; N, 115.770&#xb0; E), China. Voucher specimens of these commercial samples (Voucher number: CN-WH-01) were deposited at the School of Pharmacy, University College London, for future reference. Full details of the purchase information of the chemicals, solvents, buffers, and culture medium used in the experiments are provided in <xref ref-type="sec" rid="s13">Supplementary Table S1</xref>.</p>
</sec>
<sec id="s2-2">
<label>2.2</label>
<title>Plant extracts preparation</title>
<p>Leaves and stems of ACV were pulverized together and passed through a 60-mesh sieve. Powdered plant material (100&#xa0;mg/mL) was vortexed briefly in one of the following solvents: water, ethanol, methanol, acetone or ethyl acetate, and extracted by ultrasound-assisted extraction. Briefly, the vortexed vial containing plant powder and solvents was fixed on a floating foam rack and placed into an ultrasonic bath (Grant, XUBA3, 44&#xa0;KHz, 35&#xa0;W) for 30&#xa0;min at room temperature. The resulting supernatants were centrifuged (14,100 &#xd7; g for 10&#xa0;min) and filtered through a 0.45&#xa0;&#xb5;m PTFE syringe filter, dried by evaporation or freeze-drying, weighed, and stored at &#x2212;20&#xa0;&#xb0;C in the dark.</p>
</sec>
<sec id="s2-3">
<label>2.3</label>
<title>High-performance thin layer chromatography (HPTLC)</title>
<p>Since the species is not included in a relevant pharmacopoeia and based on the ConPhyMP standards, a simplified protocol was used to characterize the extract (<xref ref-type="bibr" rid="B19">Heinrich et al., 2022</xref>). Extracts were redissolved in their original solvents to a concentration of 5&#xa0;mg/mL. Aliquots (8&#xa0;&#xb5;L) were applied as 8&#xa0;mm bands on HPTLC silica gel 60 F254 plates (Merck KGaA, Darmstadt) using a CAMAG&#xae; Linomat 5 sample applicator (CAMAG, Muttenz, Switzerland). Plates were developed using an Automatic Developing Chamber 2 (ADC 2, CAMAG) in a saturated twin-through glass chamber with a mobile phase of toluene: ethyl acetate (8:2, v/v) as described by Kumar et al. (<xref ref-type="bibr" rid="B35">Kumar Sagar et al., 2022</xref>). The development process involved saturation (20&#xa0;min), activation (10&#xa0;min), and pre-drying (5&#xa0;min), all at 33% humidity. Plates were derivatized with 1% vanillin&#x2013;sulfuric acid using a 022.6030 CAMAG&#xae; Derivatizer (CAMAG), and visualized under white light, 254&#xa0;nm and 366&#xa0;nm UV light before and after derivatization (TLC visualizer 3, CAMAG).</p>
</sec>
<sec id="s2-4">
<label>2.4</label>
<title>UV/Vis spectrometry</title>
<p>Dried acetone and methanol extracts of ACV were reconstituted in dimethyl sulfoxide (DMSO) to yield stock solutions at a concentration of 100&#xa0;mg/mL. Working solutions were prepared by serial dilution in DMSO to 250&#xa0;&#x3bc;g/mL (acetone extract) and 500&#xa0;&#x3bc;g/mL (methanol extract). Absorbance spectra were recorded from 380 to 780&#xa0;nm using a UV/Vis spectrophotometer (JENWAY 7250, Cole-Parmer, Staffordshire, UK) with DMSO serving as the blank.</p>
</sec>
<sec id="s2-5">
<label>2.5</label>
<title>High-performance liquid chromatography (HPLC)</title>
<p>Dried ACVM were reconstituted in methanol at a concentration of 1&#xa0;mg/mL. Standard solutions of chlorogenic acid and rutin were prepared in methanol at concentrations of 1,000, 500, 250, 100, 50, 25, 12.5, 5, 1, and 0.1&#xa0;&#x3bc;g/mL. All samples were filtered through 0.22&#xa0;&#xb5;m PTFE syringe filters before analysis.</p>
<p>HPLC analysis was conducted using an Agilent 1,260 Infinity II system equipped with a variable wavelength detector (Agilent Technologies, Santa Clara, CA, United States). Data acquisition and processing were performed using OpenLab ChemStation software (Agilent Technologies). Separation was achieved on an InfinityLab Poroshell 120&#xa0;EC-C18 column (4.6 &#xd7; 150&#xa0;mm; Agilent Technologies, UK). Samples were stored in amber HPLC vials to protect from light prior to injection. HPLC conditions were adapted from <xref ref-type="bibr" rid="B68">Zeb and Ullah (2017)</xref> (<xref ref-type="bibr" rid="B68">Zeb and Ullah, 2017</xref>) with modifications for improved separation. A gradient elution was employed, with solvent A comprising 0.1% (v/v) acetic acid in water, and solvent B being methanol. The flow rate was maintained at 1&#xa0;mL/min, with an injection volume of 20&#xa0;&#xb5;L and a column temperature of 30&#xa0;&#xb0;C. Detection was performed at 280&#xa0;nm. The gradient profile is described in <xref ref-type="table" rid="T1">Table 1</xref>.</p>
<table-wrap id="T1" position="float">
<label>TABLE 1</label>
<caption>
<p>Gradient elution system for <italic>Adiantum capillus-veneris</italic>.</p>
</caption>
<table>
<thead valign="top">
<tr style="background-color:#AEAAAA">
<th align="center">ROW ID</th>
<th align="center">Time (min)</th>
<th align="center">Solvent A (0.1% (v/v) acetic acid in water) (%)</th>
<th align="center">Solvent B (Methanol) (%)</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="center">1</td>
<td align="center">5</td>
<td align="center">85</td>
<td align="center">15</td>
</tr>
<tr>
<td align="center">2</td>
<td align="center">25</td>
<td align="center">50</td>
<td align="center">50</td>
</tr>
<tr>
<td align="center">3</td>
<td align="center">30</td>
<td align="center">0</td>
<td align="center">100</td>
</tr>
<tr>
<td align="center">4</td>
<td align="center">60</td>
<td align="center">0</td>
<td align="center">100</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="s2-6">
<label>2.6</label>
<title>Cell culture</title>
<p>The human immortalized keratinocyte cell line HaCaT was obtained from Caltag Medsystems Ltd. (Buckingham, UK) and cultured in Dulbecco&#x2019;s Modified Eagle Medium (DMEM), supplemented with 10% FBS and 1% penicillin&#x2013;streptomycin. Cells were maintained at 37&#xa0;&#xb0;C in a humidified incubator with 5% CO<sub>2</sub>.</p>
<p>The murine macrophage-like cell line RAW 264.7 was kindly provided by Prof. Munoz (University of Cordoba, Spain) and cultured under the same conditions as HaCaT cells.</p>
</sec>
<sec id="s2-7">
<label>2.7</label>
<title>Visible light phototherapy protocol and sulforhodamine B (SRB) assay</title>
<p>The dried ACVM obtained in <xref ref-type="sec" rid="s2-2">Section 2.2</xref> was re-dissolved in DMSO to prepare a 100&#xa0;mg/mL stock solution, which was subsequently diluted with culture medium to the desired working concentrations prior to treatment, and this stock solution was used for subsequent tests.</p>
<p>HaCaT cells were seeded in 96-well plates (Corning&#xae;, CLS3596, Corning Inc., Corning, NY, United States) at a density of 1 &#xd7; 10<sup>4</sup> cells per well and incubated overnight to allow adherence. The cells were then exposed to fresh medium containing ACVM (diluted from stock solution) to reach the working concentrations of 1, 10, 50, 100, and 200&#xa0;&#x3bc;g/mL for a total of 48&#xa0;h under cell culture conditions. Control treatments included blank control (no treatment, medium-only), solvent control (0.2% DMSO, corresponding to the final DMSO concentration after diluting the 100&#xa0;mg/mL stock solution 500-fold in DMEM) and positive control (epidermal growth factor, EGF) at 10&#xa0;ng/mL. To assess the influence of visible light exposure, two identical plates were prepared. Following a 5-h pre-treatment with the plant extracts, the light exposure group was irradiated in the presence of extracts, using a LED light source (NorbSMILE; 380&#x2013;780&#xa0;nm, 9&#xa0;W, 680 lumens, 7,450 lx) placed 15&#xa0;cm above the culture surface for 30&#xa0;min, after which incubation was continued until the 48&#xa0;h endpoint. Another plate was kept in the dark. Both sets were then incubated for a total of 48&#xa0;h under cell culture conditions in the dark.</p>
<p>Thereafter, cell viability was assessed using the sulforhodamine B (SRB) assay, which quantifies cell numbers by measuring total protein content. Measurements were conducted according to the method of <xref ref-type="bibr" rid="B61">Vichai and Kirtikara (2006)</xref> (<xref ref-type="bibr" rid="B61">Vichai and Kirtikara, 2006</xref>). Cells were fixed by adding 100&#xa0;&#xb5;L of 10% (w/v) trichloroacetic acid and incubated at 4&#xa0;&#xb0;C for 1&#xa0;h. The plates were then washed five times with tap water and air-dried. Subsequently, 100&#xa0;&#x3bc;L of 0.057% (w/v) SRB was added to each well and incubated at room temperature for 30&#xa0;min. Unbound dye was removed by rinsing five times with 1% (v/v) acetic acid, followed by air-drying. Protein-bound dye was solubilized with 200&#xa0;&#xb5;L of 10&#xa0;mM Tris base, and plates were shaken for 20&#xa0;min. Absorbance was recorded at 515&#xa0;nm using a microplate reader (Infinite M200; Tecan Group Ltd., M&#xe4;nnedorf, Switzerland). Cell proliferation was expressed as a relative ratio calculated using the following equation:<disp-formula id="equ1">
<mml:math id="m1">
<mml:mrow>
<mml:mtext>Relative&#x2009;proliferation&#x2009;ratio</mml:mtext>
<mml:mo>&#x3d;</mml:mo>
<mml:mfrac>
<mml:mrow>
<mml:mi>O</mml:mi>
<mml:mi>D</mml:mi>
<mml:mrow>
<mml:mfenced open="(" close=")" separators="|">
<mml:mrow>
<mml:mi>t</mml:mi>
<mml:mi>r</mml:mi>
<mml:mi>e</mml:mi>
<mml:mi>a</mml:mi>
<mml:mi>t</mml:mi>
<mml:mi>m</mml:mi>
<mml:mi>e</mml:mi>
<mml:mi>n</mml:mi>
<mml:mi>t</mml:mi>
</mml:mrow>
</mml:mfenced>
</mml:mrow>
<mml:mo>&#x2212;</mml:mo>
<mml:mi>O</mml:mi>
<mml:mi>D</mml:mi>
<mml:mrow>
<mml:mfenced open="(" close=")" separators="|">
<mml:mrow>
<mml:mi>b</mml:mi>
<mml:mi>l</mml:mi>
<mml:mi>a</mml:mi>
<mml:mi>n</mml:mi>
<mml:mi>k</mml:mi>
</mml:mrow>
</mml:mfenced>
</mml:mrow>
</mml:mrow>
<mml:mrow>
<mml:mi>O</mml:mi>
<mml:mi>D</mml:mi>
<mml:mrow>
<mml:mfenced open="(" close=")" separators="|">
<mml:mrow>
<mml:mi>c</mml:mi>
<mml:mi>o</mml:mi>
<mml:mi>n</mml:mi>
<mml:mi>t</mml:mi>
<mml:mi>r</mml:mi>
<mml:mi>o</mml:mi>
<mml:mi>l</mml:mi>
</mml:mrow>
</mml:mfenced>
</mml:mrow>
<mml:mo>&#x2212;</mml:mo>
<mml:mi>O</mml:mi>
<mml:mi>D</mml:mi>
<mml:mrow>
<mml:mfenced open="(" close=")" separators="|">
<mml:mrow>
<mml:mi>b</mml:mi>
<mml:mi>l</mml:mi>
<mml:mi>a</mml:mi>
<mml:mi>n</mml:mi>
<mml:mi>k</mml:mi>
</mml:mrow>
</mml:mfenced>
</mml:mrow>
<mml:mtext>&#x2009;</mml:mtext>
</mml:mrow>
</mml:mfrac>
<mml:mo>&#xd7;</mml:mo>
<mml:mn>100</mml:mn>
<mml:mo>%</mml:mo>
</mml:mrow>
</mml:math>
</disp-formula>
</p>
</sec>
<sec id="s2-8">
<label>2.8</label>
<title>Scratch assay</title>
<p>The scratch assay protocol was based on <xref ref-type="bibr" rid="B36">Liang et al. (2007)</xref> (<xref ref-type="bibr" rid="B36">Liang et al., 2007</xref>). HaCaT cells were seeded in 12-well plates (Corning&#xae;, CLS356500) at a density of 2 &#xd7; 10<sup>5</sup> cells per well and cultured to approximately 90% confluence. To prevent proliferation-driven closure of the scratch and eliminate potential false-positive results, cells were pre-treated with 5&#xa0;&#x3bc;g/mL mitomycin C for 2&#xa0;h prior to wounding, followed by thorough washing with PBS. A linear scratch was introduced with PBS inside the well manually, using a sterile 200&#xa0;&#xb5;L pipette tip guided by a ruler to ensure consistency. Before wounding, three reference marks were drawn on the underside of each well to aid in image alignment. After scratching, the monolayer was gently washed with PBS to remove detached cells and debris. Cells were then treated with culture medium containing ACVM to final working concentrations of 1, 10, 50, and 100&#xa0;&#x3bc;g/mL in each well for 24&#xa0;h. Control treatments included blank control (medium-only), solvent control (0.1% DMSO, corresponding to the final DMSO concentration after diluting the 100&#xa0;mg/mL stock solution 1000-fold in DMEM) and positive control (10&#xa0;ng/mL EGF). For light control group, the same visible light phototherapy protocol as described in <xref ref-type="sec" rid="s2-7">Section 2.7</xref> assay was applied after the exposure of scratch wounds to ACVM extracts.</p>
<p>Images were captured at 0, 12, and 24&#xa0;h post-wounding using the EVOS M5000 Imaging System (Thermo Fisher Scientific). Wound closure was quantified by analyzing the scratch area using ImageJ (version 1.53t), and the percentage of migration was calculated as follows:<disp-formula id="equ2">
<mml:math id="m2">
<mml:mrow>
<mml:mtext>Migration&#x2009;rate</mml:mtext>
<mml:mo>&#x3d;</mml:mo>
<mml:mfrac>
<mml:mrow>
<mml:mi>I</mml:mi>
<mml:mi>n</mml:mi>
<mml:mi>i</mml:mi>
<mml:mi>t</mml:mi>
<mml:mi>i</mml:mi>
<mml:mi>a</mml:mi>
<mml:mi>l</mml:mi>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mi>W</mml:mi>
<mml:mi>o</mml:mi>
<mml:mi>u</mml:mi>
<mml:mi>n</mml:mi>
<mml:mi>d</mml:mi>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mi>A</mml:mi>
<mml:mi>r</mml:mi>
<mml:mi>e</mml:mi>
<mml:mi>a</mml:mi>
<mml:mo>&#x2212;</mml:mo>
<mml:mi>R</mml:mi>
<mml:mi>e</mml:mi>
<mml:mi>m</mml:mi>
<mml:mi>a</mml:mi>
<mml:mi>i</mml:mi>
<mml:mi>n</mml:mi>
<mml:mi>i</mml:mi>
<mml:mi>n</mml:mi>
<mml:mi>g</mml:mi>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mi>W</mml:mi>
<mml:mi>o</mml:mi>
<mml:mi>u</mml:mi>
<mml:mi>n</mml:mi>
<mml:mi>d</mml:mi>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mi>A</mml:mi>
<mml:mi>r</mml:mi>
<mml:mi>e</mml:mi>
<mml:mi>a</mml:mi>
</mml:mrow>
<mml:mrow>
<mml:mi>I</mml:mi>
<mml:mi>n</mml:mi>
<mml:mi>n</mml:mi>
<mml:mi>i</mml:mi>
<mml:mi>t</mml:mi>
<mml:mi>i</mml:mi>
<mml:mi>a</mml:mi>
<mml:mi>l</mml:mi>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mi>W</mml:mi>
<mml:mi>o</mml:mi>
<mml:mi>u</mml:mi>
<mml:mi>n</mml:mi>
<mml:mi>d</mml:mi>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mi>A</mml:mi>
<mml:mi>r</mml:mi>
<mml:mi>e</mml:mi>
<mml:mi>a</mml:mi>
</mml:mrow>
</mml:mfrac>
<mml:mo>&#xd7;</mml:mo>
<mml:mn>100</mml:mn>
<mml:mo>%</mml:mo>
</mml:mrow>
</mml:math>
</disp-formula>
</p>
</sec>
<sec id="s2-9">
<label>2.9</label>
<title>2&#x2032;, 7&#x2032;-Dichlorodihydrofluorescein diacetate (DCFH-DA) assay</title>
<p>Intracellular ROS levels were quantified using the DCFH-DA assay adapted from <xref ref-type="bibr" rid="B31">Kim et al. (2021)</xref> (<xref ref-type="bibr" rid="B31">Kim et al., 2021</xref>), and the fluorescence intensity was measured by a plate reader. This method provides quantitative data rather than microscopic images.</p>
<p>HaCaT cells were seeded in black 96-well plates (Corning&#xae;, CLS3631) at a density of 1 &#xd7; 10<sup>5</sup> cells per well and incubated overnight under cell culture conditions. Cells were then treated for 24&#xa0;h with culture medium diluted ACVM stock solution at working concentrations of 1, 10, 50 and 100&#xa0;&#x3bc;g/mL, or with 10&#xa0;&#x3bc;g/mL l-ascorbic acid as a positive control. To investigate the effect of light, two identical plates were prepared, and one was subjected to the same visible light phototherapy protocol as described in <xref ref-type="sec" rid="s2-7">Section 2.7</xref>. Following treatment, cells were exposed to 0.003% (&#x223c;800&#xa0;&#x3bc;M) hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>) for 1&#xa0;h at 37&#xa0;&#xb0;C to induce oxidative stress. After stimulation, cells were washed with serum-free medium to remove residual H<sub>2</sub>O<sub>2</sub>. Subsequently, 100&#xa0;&#x3bc;L of 10&#xa0;&#x3bc;M DCFH-DA was added to each well and incubated for 30&#xa0;min at 37&#xa0;&#xb0;C in the dark. Excess dye was removed by washing with serum-free medium, and 50&#xa0;&#x3bc;L of fresh serum-free medium was added. Fluorescence intensity was measured using a microplate reader (excitation: 488&#xa0;nm; emission: 525&#xa0;nm; Infinite M200; Tecan Group Ltd., M&#xe4;nnedorf, Switzerland) to quantify intracellular ROS levels. Three replicates were set for each treatment and 6 independent measurements were performed.</p>
</sec>
<sec id="s2-10">
<label>2.10</label>
<title>3-[4, 5-dimethylthiazol-2-yl]-2, 5 diphenyl tetrazolium bromide (MTT) assay</title>
<p>The MTT protocol followed standard laboratory procedure and is based on <xref ref-type="bibr" rid="B55">Sun et al. (2024b)</xref>. RAW 264.7 cells were seeded into 96-well plates (Corning&#xae;, CLS3596) at a density of 1 &#xd7; 10<sup>5</sup> cells per well and incubated overnight under cell culture conditions to allow for adherence. The next day, the medium was replaced with fresh medium containing ACVM, prepared by diluting the stock solution with culture medium to final working concentrations of 0.1, 1, 10, or 50&#xa0;&#x3bc;g/mL, and cells were incubated for 30&#xa0;min. Thereafter, lipopolysaccharide (LPS; 100&#xa0;ng/mL; <italic>E. coli</italic> O127:B8; Sigma-Aldrich, Taufkirchen, Germany) was additionally pipetted to the wells, and cells were incubated for 20&#xa0;h. Subsequently, 20&#xa0;&#x3bc;L of MTT solution (Merck KGaA, Darmstadt, Germany) was added to each well and incubated for an additional 4&#xa0;h. The supernatant was carefully removed, and the resulting formazan crystals were solubilized in DMSO. Absorbance was measured at 595&#xa0;nm using an MRXe microplate reader (Dynex Technologies, Denkendorf, Germany).</p>
</sec>
<sec id="s2-11">
<label>2.11</label>
<title>Enzyme-linked immunosorbent assay (ELISA)</title>
<p>ELISA was performed according to established laboratory protocol (<xref ref-type="bibr" rid="B55">Sun et al., 2024b</xref>), with adaptations for the different cell lines used in this study. RAW 264.7 cells were seeded in 96-well plates (Corning&#xae;, CLS3596) at a density of 1 &#xd7; 10<sup>5</sup> cells/well and incubated overnight. Cells were treated with ACVM diluted in culture medium to working concentrations of 0.1, 1,10 and 50&#xa0;&#x3bc;g/mL for 30&#xa0;min, after which LPS was added at a final working concentration of 100&#xa0;ng/mL in each well, followed by incubation for 24&#xa0;h. Culture supernatants were collected and centrifuged at 1,000 &#xd7; g for 5&#xa0;min at 4&#xa0;&#xb0;C. Concentrations of tumor necrosis factor alpha (TNF-&#x3b1;), interleukin 6 (IL-6), C-X-C motif chemokine ligand 10 (CXCL10), C-X-C motif chemokine ligand 2 (CXCL2), and C-C motif chemokine ligand 2 (CCL2) were measured using commercial ELISA kits (cat. nos. DY410, DY406, DY466, DY452, and DY479; Bio-Techne GmbH, Wiesbaden, Germany) that contain all necessary antibodies, standards, and solutions, according to the manufacturer&#x2019;s protocols.</p>
<p>Briefly, 96-well plates were coated with capture antibodies and incubated overnight at 4&#xa0;&#xb0;C. Plates were washed and blocked, then incubated with serially diluted recombinant mouse cytokine/chemokine standards and test samples. Following additional washing steps, detection antibodies were added and incubated for 2&#xa0;h, followed sequentially by streptavidin-HRP, 1x 3,3&#x2032;,5,5&#x2032;-tetramethylbenzidine (TMB) solution and stop solution (2&#xa0;N H<sub>2</sub>SO<sub>4</sub>). Absorbance was read at 450&#xa0;nm using an MRXe microplate reader (Dynex Technologies).</p>
</sec>
<sec id="s2-12">
<label>2.12</label>
<title>Statistical analysis</title>
<p>Statistical analyses were conducted using IBM SPSS Statistics for MacOS, version 29.0.0.0 (241) (IBM Corp., Armonk, NY, United States), while graphical representations were generated using GraphPad Prism for MacOS, version 9.5.0 (525) (GraphPad Software Inc., San Diego, CA, United States). Data are presented as mean &#xb1; standard deviation (SD) from a minimum of three independent biological replicates and were analyzed using one-way ANOVA. Statistical significance was defined as <italic>p &#x3c; 0.05 (&#x2a;), p &#x3c; 0.01 (&#x2a;&#x2a;),</italic> and <italic>p &#x3c; 0.001 (&#x2a;&#x2a;&#x2a;)</italic> as indicated above the corresponding bars.</p>
</sec>
</sec>
<sec sec-type="results|discussion" id="s3">
<label>3</label>
<title>Results and discussions</title>
<sec id="s3-1">
<label>3.1</label>
<title>High-performance thin layer chromatographic analysis</title>
<p>HPTLC was utilized to assess the extraction performance of solvents with different polarities (water, ethanol, methanol, acetone, and ethyl acetate), based on their ability to extract a broad range of metabolites. The developing solvent system was Toluene: EtOAc (8:2, v/v), based on <xref ref-type="bibr" rid="B35">Kumar Sagar et al., 2022</xref>; <xref ref-type="bibr" rid="B35">Kumar Sagar et al., 2022</xref>). A total of 15 distinct bands were revealed in ACVM under all visualization conditions, followed by the ethanol and acetone extracts, each displaying 14 bands. Thirteen bands were found in the ethyl acetate extract, and only two bands were observed in the aqueous extract. The Rf values corresponding to the bands detected in each extract are summarized in <xref ref-type="table" rid="T2">Table 2</xref>. Notably, the methanol extract exhibited stronger band intensities compared to the other solvent extracts, particularly at Rf values of 0.83, 0.72, and 0.64. The HPTLC profiles under different light sources before or after derivatization are presented in the <xref ref-type="sec" rid="s13">Supplementary Figures S2&#x2013;S4</xref>.</p>
<table-wrap id="T2" position="float">
<label>TABLE 2</label>
<caption>
<p>Rf value of each marked visualized band in different extracts of <italic>Adiantum capillus-veneris</italic>.</p>
</caption>
<table>
<thead valign="top">
<tr style="background-color:#AEAAAA">
<th align="center">
<italic>A. capillus-veneris</italic> L</th>
<th align="center">Water</th>
<th align="center">Ethanol</th>
<th align="center">Methanol</th>
<th align="center">Acetone</th>
<th align="center">EtOAc</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td rowspan="15" align="center">
<italic>Rf</italic> Value</td>
<td rowspan="12" align="left"/>
<td align="center">0.83</td>
<td align="center">0.83</td>
<td align="center">0.83</td>
<td align="center">0.83</td>
</tr>
<tr>
<td align="center">0.80</td>
<td align="center">0.80</td>
<td align="center">0.80</td>
<td align="center">0.80</td>
</tr>
<tr>
<td align="center">0.72</td>
<td align="center">0.72</td>
<td align="center">0.72</td>
<td align="center">0.72</td>
</tr>
<tr>
<td align="center">0.64</td>
<td align="center">0.64</td>
<td align="center">0.64</td>
<td align="center">0.64</td>
</tr>
<tr>
<td align="center">0.59</td>
<td align="center">0.59</td>
<td align="center">0.59</td>
<td align="center">0.59</td>
</tr>
<tr>
<td align="center">0.55</td>
<td align="center">0.55</td>
<td align="center">0.55</td>
<td align="center">0.55</td>
</tr>
<tr>
<td align="center">0.52</td>
<td align="center">0.52</td>
<td align="center">0.52</td>
<td align="center">0.52</td>
</tr>
<tr>
<td align="center">0.48</td>
<td align="center">0.48</td>
<td align="center">0.48</td>
<td align="center">0.48</td>
</tr>
<tr>
<td align="center">0.40</td>
<td align="center">0.40</td>
<td align="center">0.40</td>
<td align="center">0.40</td>
</tr>
<tr>
<td align="center">0.24</td>
<td align="center">0.24</td>
<td align="center">0.24</td>
<td align="center">0.24</td>
</tr>
<tr>
<td align="center">0.23</td>
<td align="center">0.23</td>
<td align="center">0.23</td>
<td align="left"/>
</tr>
<tr>
<td align="center">0.22</td>
<td align="center">0.22</td>
<td align="center">0.22</td>
<td align="center">0.22</td>
</tr>
<tr>
<td align="center">0.16</td>
<td align="center">0.16</td>
<td align="center">0.16</td>
<td align="left"/>
<td align="left"/>
</tr>
<tr>
<td align="center">0.13</td>
<td align="center">0.13</td>
<td align="center">0.13</td>
<td align="center">0.13</td>
<td align="center">0.13</td>
</tr>
<tr>
<td align="left"/>
<td align="left"/>
<td align="center">0.10</td>
<td align="center">0.10</td>
<td align="center">0.10</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>Based on HPTLC results, it was observed that polar organic solvents (e.g., ethanol and methanol) extracted a higher number of metabolites than less-polar solvents (e.g., acetone and ethyl acetate) and water. Methanol exhibited the highest extraction performance compared with other solvents, suggesting that the secondary metabolites in this plant are predominantly polar or semi-polar. Notably, water exhibited the lowest extraction yield. Although water is more polar than methanol, its high viscosity and poor permeability limit its ability to penetrate plant cells. As a result, even if certain metabolites are water-soluble, they may remain trapped within the cells, leading to a lower overall extraction yield (<xref ref-type="bibr" rid="B5">Basri and Nor, 2014</xref>).</p>
</sec>
<sec id="s3-2">
<label>3.2</label>
<title>UV/Vis spectroscopy</title>
<p>Methanol extracts were initially selected for UV/Vis analysis based on HPTLC results. However, considering that less polar metabolites with potential photoactive properties might not be efficiently extracted by methanol alone, the acetone extract was subsequently included as a representative of less polar solvent extracts. This approach allowed broader metabolite coverage across different polarity ranges while minimizing sample consumption.</p>
<p>This is the first report on visible light absorption spectra of methanol and acetone extracts of ACV. In UV/Vis spectrometry, both acetone (250&#xa0;&#x3bc;g/mL) and methanol (500&#xa0;&#x3bc;g/mL) extracts showed a similar pattern with a strong band of 420&#xa0;nm in the Soret region, a smaller peak at 460&#xa0;nm, a major Q band at 666&#xa0;nm and two minor Q bands at 537&#xa0;nm and 613&#xa0;nm (<xref ref-type="fig" rid="F1">Figure 1</xref>). This spectral fingerprint may indicate the dominant presence of porphyrin-type pigments, including chlorophyll derivatives such as pheophytin (<xref ref-type="bibr" rid="B27">Kang et al., 2018</xref>; <xref ref-type="bibr" rid="B58">Taniguchi and Lindsey, 2021</xref>). The efficient absorbance in the 600&#x2013;700&#xa0;nm range matches the established therapeutic window of PDT, enabling the generation of singlet oxygen or ROS under visible (red) light application at a clinically relevant tissue depth (<xref ref-type="bibr" rid="B37">Mallidi et al., 2016</xref>).</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>UV/Vis absorption spectra of acetone and methanol extracts of ACV in the visible light wavelength range (380&#xa0;nm&#x2013;780&#xa0;nm).</p>
</caption>
<graphic xlink:href="fphar-16-1729572-g001.tif">
<alt-text content-type="machine-generated">Graph illustrating the absorbance spectra of Adiantum capillus-veneris L. for acetone and methanol (MeOH) extracts. The acetone extract shows peaks at 420 nm (2.469 AU), 460 nm (1.516 AU), and 666 nm (1.015 AU), while the MeOH extract exhibits peaks at 420 nm (2.086 AU), 460 nm (1.348 AU), and 666 nm (0.870 AU). Additional measurements include 537 nm and 613 nm with lower absorbance values for both extracts.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s3-3">
<label>3.3</label>
<title>High-performance liquid chromatography-based quantification of rutin and chlorogenic acid</title>
<p>The quantification of chlorogenic acid and rutin in the ACVM was performed using an Agilent 1,260 Infinity II HPLC system, with a detection wavelength set at 280&#xa0;nm. Multiple reviews report the presence of triterpenoids, flavonoids, phenylpropanoids/phenolic acids, saponins and steroids in ACV (<xref ref-type="bibr" rid="B12">Dehdari and Hajimehdipoor, 2018</xref>; <xref ref-type="bibr" rid="B22">Jaafer et al., 2025</xref>; <xref ref-type="bibr" rid="B46">Qadir et al., 2025</xref>). Among these, flavonoids and phenylpropanoid-type phenolic acids are particularly relevant to the present study, as they possess conjugated aromatic systems. For example, rutin (a flavonol glycoside) and chlorogenic acid (a phenylpropanoid-type phenolic acid) were selected as marker compounds due to their <italic>in vivo</italic> demonstrated relevance to wound repair (<xref ref-type="bibr" rid="B3">Almeida et al., 2012</xref>; <xref ref-type="bibr" rid="B8">Chen et al., 2013</xref>; <xref ref-type="bibr" rid="B10">Chen et al., 2020</xref>; <xref ref-type="bibr" rid="B1">Al-Ghanayem et al., 2024</xref>) and stable chromatographic detectability, which here provides a focused preliminary chemical characterization rather than exhaustive profiling. Their reported photoreactivity further supports their relevance to the light-assisted activity examined here (<xref ref-type="bibr" rid="B6">Bhattacharyya et al., 2014</xref>; <xref ref-type="bibr" rid="B11">Choi et al., 2014</xref>). Identification was achieved by matching the retention times of peaks in the sample with those of reference standards. The HPLC chromatogram of the methanol extract is shown in <xref ref-type="fig" rid="F2">Figure 2</xref>. The retention time, peak area, and peak height of the main metabolites are summarized in <xref ref-type="table" rid="T3">Table 3</xref>. The methanolic extract was analyzed at a concentration of 1&#xa0;mg/mL.</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>HPLC profile of crude methanol extract of <italic>Adiantum capillus-veneris</italic>. Peaks at retention time of 11.168&#xa0;min and 22.599&#xa0;min were identified as chlorogenic acid and rutin, respectively. The detection was set at 280&#xa0;nm (InfinityLab Poroshell 120&#xa0;EC-C18 column, 4.6 &#xd7; 150&#xa0;mm).</p>
</caption>
<graphic xlink:href="fphar-16-1729572-g002.tif">
<alt-text content-type="machine-generated">Chromatogram depicting absorbance at 280 nanometers over a retention time of sixty minutes. Peaks labeled for chlorogenic acid around twelve minutes and rutin around twenty-four minutes. Peaks are measured in milli absorbance units (mAU).</alt-text>
</graphic>
</fig>
<table-wrap id="T3" position="float">
<label>TABLE 3</label>
<caption>
<p>Retention time, area, height, and area% of peaks detected in crude methanol extract of <italic>Adiantum capillus-veneris.</italic>
</p>
</caption>
<table>
<thead valign="top">
<tr style="background-color:#AEAAAA">
<th align="center">RT (min)</th>
<th align="center">Area</th>
<th align="center">Height</th>
<th align="center">Area %</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="center">10.839</td>
<td align="center">1742.7</td>
<td align="center">83.6</td>
<td align="center">10.64</td>
</tr>
<tr>
<td align="center">11.168</td>
<td align="center">2079.1</td>
<td align="center">271.1</td>
<td align="center">12.69</td>
</tr>
<tr>
<td align="center">11.886</td>
<td align="center">167.6</td>
<td align="center">11.9</td>
<td align="center">1.02</td>
</tr>
<tr>
<td align="center">13.903</td>
<td align="center">1,008.9</td>
<td align="center">62.6</td>
<td align="center">6.16</td>
</tr>
<tr>
<td align="center">14.188</td>
<td align="center">2022.7</td>
<td align="center">246.9</td>
<td align="center">12.35</td>
</tr>
<tr>
<td align="center">16.278</td>
<td align="center">225.6</td>
<td align="center">23.7</td>
<td align="center">1.38</td>
</tr>
<tr>
<td align="center">16.932</td>
<td align="center">960</td>
<td align="center">70.6</td>
<td align="center">5.86</td>
</tr>
<tr>
<td align="center">17.733</td>
<td align="center">662.4</td>
<td align="center">28.6</td>
<td align="center">4.04</td>
</tr>
<tr>
<td align="center">20.836</td>
<td align="center">545</td>
<td align="center">46</td>
<td align="center">3.33</td>
</tr>
<tr>
<td align="center">21.697</td>
<td align="center">231.4</td>
<td align="center">21.4</td>
<td align="center">1.41</td>
</tr>
<tr>
<td align="center">22.599</td>
<td align="center">75.810</td>
<td align="center">7.790</td>
<td align="center">0.463</td>
</tr>
<tr>
<td align="center">24.181</td>
<td align="center">2,367.1</td>
<td align="center">201.7</td>
<td align="center">14.45</td>
</tr>
<tr>
<td align="center">32.172</td>
<td align="center">535.7</td>
<td align="center">142.5</td>
<td align="center">3.27</td>
</tr>
<tr>
<td align="center">41.484</td>
<td align="center">885.1</td>
<td align="center">75.5</td>
<td align="center">5.4</td>
</tr>
<tr>
<td align="center">52.053</td>
<td align="center">300.8</td>
<td align="center">9.5</td>
<td align="center">1.84</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>Calibration curves were constructed using eight concentration points, spanning from 5&#xa0;&#x3bc;g/mL to 1,000&#xa0;&#x3bc;g/mL. The calibration curve for chlorogenic acid was described by the equation y &#x3d; 19.511x&#x2b;148.17, with a correlation coefficient (<italic>R</italic>
<sup>2</sup>) of 0.999. For rutin, the calibration equation was y &#x3d; 8.4964x&#x2212;85.257, yielding an <italic>R</italic>
<sup>2</sup> value of 0.998. The curves were derived by plotting the peak area <italic>versus</italic> the known concentrations of the respective standards. Based on these calibration data, the concentrations of chlorogenic acid and rutin in the crude methanol extract (1&#xa0;mg/mL) were determined to be 99.99&#xa0;&#x3bc;g/mL and 18.96&#xa0;&#x3bc;g/mL, respectively. The residual method was employed to determine the limits of detection (LOD) and quantification (LOQ) using the equations LOD &#x3d; 3.3&#x3c3;/S and LOQ &#x3d; 10&#x3c3;/S, where &#x3c3; is the standard deviation of the residuals and S is the slope of the calibration curve. The calculated LOD and LOQ values for chlorogenic acid were 16.28&#xa0;&#x3bc;g/mL and 49.33&#xa0;&#x3bc;g/mL, respectively, while those for rutin were 22.53&#xa0;&#x3bc;g/mL and 68.26&#xa0;&#x3bc;g/mL. The measured concentration of chlorogenic acid exceeded its LOQ, indicating its relatively high abundance, whereas the concentration of rutin was below its LOD.</p>
<p>Although rutin was detected, its signal intensity was weak. While rutin is frequently reported as a major flavonoid constituent of ACV (<xref ref-type="bibr" rid="B42">Nilforoushzadeh et al., 2014</xref>; <xref ref-type="bibr" rid="B2">Al-Khesraji and Maulood, 2017</xref>), <xref ref-type="bibr" rid="B2">Al-Khesraji and Maulood (2017)</xref> demonstrated that rutin abundance can vary substantially among samples from different geographical sources (<xref ref-type="bibr" rid="B2">Al-Khesraji and Maulood, 2017</xref>). Together with findings from this study, suggest that variations in compound composition linked to plant origin may influence the bioactivity of ACV extracts, and their potential relevance to photodynamic effects. To better characterise the constituents contributing to light-assisted wound-healing activity, further analyses are planned using LC&#x2013;MS/MS to identify more abundant metabolites in the methanol extract, particularly flavonols such as kaempferol, quercetin and their derivatives, which have been reported to exhibit anti-inflammatory, antioxidant and wound-healing activities (<xref ref-type="bibr" rid="B46">Qadir et al., 2025</xref>). In addition, a comparative assessment of samples from different regions will be undertaken to determine whether geographical variability in chemical profiles may affect PDT-related activity.</p>
</sec>
<sec id="s3-4">
<label>3.4</label>
<title>Effects of methanolic extract on keratinocyte viability</title>
<p>The SRB assay was performed to exclude possible cytotoxic effects of ACVM on HaCaT cells. Under both tested conditions (without and with light), positive controls with 10&#xa0;ng/mL EGF significantly enhanced cell viability, whereas solvent controls with 0.2% DMSO showed no effect compared with untreated cells (medium-only). As shown in <xref ref-type="fig" rid="F3">Figure 3</xref>, in the dark, none of the ACVM concentrations tested (1&#x2013;200&#xa0;&#x3bc;g/mL) elicited a biologically relevant effect on the viability of HaCaT cells (viability at the highest concentration of 200&#xa0;&#x3bc;g/mL: 91.91% &#xb1; 2.53% compared to the solvent control). Despite the presence of photosensitizers, exposure of ACVM-treated cells to visible light for 30&#xa0;min did not reduce the cell viability below about 90% (viability at 200&#xa0;&#x3bc;g/mL: 92.31% &#xb1; 3.63% and 100&#xa0;&#x3bc;g/mL: 92.70% &#xb1; 3.47% compared to the untreated group) (<xref ref-type="fig" rid="F3">Figure 3</xref>), indicating that unwanted photodynamic cell killing was negligible. Under the conditions used in our study, the methanolic extract can thus be considered as nontoxic and safe to use for wound healing assays, even under light exposure. In subsequent experiments, the plant extract was applied at concentrations up to 100&#xa0;&#x3bc;g/mL.</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption>
<p>Effect of ACVM on the viability of HaCaT cells after 48&#xa0;h of treatment under dark (D) conditions or 30&#xa0;min light exposure (L). Cell viability was assessed using the SRB assay. Results are expressed as the mean &#xb1; SD of six independent measurements. <italic>p</italic> &#x3c; 0.05 (&#x2a;), <italic>p</italic> &#x3c; 0.01 (&#x2a;&#x2a;) and <italic>p</italic> &#x3c; 0.001 (&#x2a;&#x2a;&#x2a;) indicate significant differences compared to the blank group under dark condition. <italic>p</italic> &#x3c; 0.05 (&#x2020;), <italic>p</italic> &#x3c; 0.01 (&#x2020;&#x2020;) and <italic>p</italic> &#x3c; 0.001 (&#x2020;&#x2020;&#x2020;) indicate significant differences compared to the blank group with 30&#xa0;min light exposure.</p>
</caption>
<graphic xlink:href="fphar-16-1729572-g003.tif">
<alt-text content-type="machine-generated">Bar graph showing relative cell viability normalized to a blank, with bars for different conditions. The x-axis labels include &#x22;D&#x22; and &#x22;L&#x22; under varying concentrations of EGF, DMSO, and ACVM. Viability ranges from 0.5 to 1.5. Significance is indicated atop several bars with symbols such as *** and &#x2020;.</alt-text>
</graphic>
</fig>
<p>Our data demonstrated that ACVM was well tolerated by HaCaT cells at concentrations up to 200&#xa0;&#x3bc;g/mL. This aligns with a previous report, which showed good tolerance of ethanolic and aqueous extracts at 100&#xa0;&#x3bc;g/mL (<xref ref-type="bibr" rid="B28">Khan et al., 2018</xref>). <italic>Nilforoushzadeh et al.</italic> reported that polar and moderately polar fractions (aqueous and butanolic) of ACVM showed no cytotoxic effect on human dermal fibroblasts up to 500&#xa0;&#x3bc;g/mL, while cytotoxicity appeared with ethyl acetate fractions at 250&#xa0;&#x3bc;g/mL and with hexane fractions at 500&#xa0;&#x3bc;g/mL. Similarly, mouse fibroblasts tolerated methanolic extracts up to 1,000&#xa0;&#x3bc;g/mL (<xref ref-type="bibr" rid="B42">Nilforoushzadeh et al., 2014</xref>; <xref ref-type="bibr" rid="B40">Negahdari et al., 2017</xref>). These discrepancies likely reflect both solvent polarity and intrinsic differences in cell-type sensitivity.</p>
</sec>
<sec id="s3-5">
<label>3.5</label>
<title>Effect of ACVM on the migration of HaCaT cells in scratch assays</title>
<p>To account for differences in initial wound shape and size and to assess whether light exposure itself influences migration, all data were normalized to the solvent control (0.1% DMSO) and expressed as fold changes relative to it. After 24&#xa0;h of treatment (<xref ref-type="fig" rid="F4">Figure 4</xref>), 0.1% DMSO alone showed no effect, whereas the positive control (10&#xa0;ng/mL EGF) significantly enhanced HaCaT migration by &#x223c;2-fold compared with the blank (medium-only).</p>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption>
<p>Effect of ACVM on migration rate of HaCaT cells in darkness (D) or with 30&#xa0;min visible light exposure (L). Data are normalized to solvent control (0.1% DMSO) group and expressed as mean &#xb1; SD of three independent measurements. <italic>p</italic> &#x3c; 0.05 (&#x2a;), <italic>p</italic> &#x3c; 0.01 (&#x2a;&#x2a;) and <italic>p</italic> &#x3c; 0.001 (&#x2a;&#x2a;&#x2a;) indicate significant differences compared to the blank group under dark condition. <italic>p</italic> &#x3c; 0.05 (&#x2020;), <italic>p</italic> &#x3c; 0.01 (&#x2020;&#x2020;) and <italic>p</italic> &#x3c; 0.001 (&#x2020;&#x2020;&#x2020;) indicate significant differences compared to the blank group with 30&#xa0;min light exposure. <italic>p</italic> &#x3c; 0.05 (&#x23;), <italic>p</italic> &#x3c; 0.01 (&#x23;&#x23;) and <italic>p</italic> &#x3c; 0.001 (&#x23;&#x23;&#x23;) indicate significant difference between the same treatment but from two light conditions group.</p>
</caption>
<graphic xlink:href="fphar-16-1729572-g004.tif">
<alt-text content-type="machine-generated">Bar graph showing the relative migration rate of cells versus 0.1% DMSO across different treatments. Treatments include combinations of EGF, DMSO, and varying concentrations of ACVM. Bars are labeled D and L, with significance indicated by symbols like ***, ##, and &#x2020;&#x2020;&#x2020;. Data shows varying levels of migration rate, with some treatments significantly increasing the rate. Error bars indicate variability.</alt-text>
</graphic>
</fig>
<p>Notably, exposure to visible light alone promoted cell migration. In the blank control, migration under darkness was 0.98 &#xb1; 0.05-fold relative to 0.1% DMSO, while light increased it to 1.22 &#xb1; 0.06-fold (<italic>p &#x3c; 0.01</italic>). A similar light-enhanced effect was observed with ACVM treatment. In darkness, ACVM significantly increased migration in a dose-dependent manner, reaching 1.50 &#xb1; 0.06-, 1.63 &#xb1; 0.04-, and 1.27 &#xb1; 0.12-fold at 10, 50, and 100&#xa0;&#x3bc;g/mL, respectively. With light exposure, these values rose further to 1.83 &#xb1; 0.11-, 2.05 &#xb1; 0.10-, and 1.58 &#xb1; 0.13-fold. Among the tested concentrations, 50&#xa0;&#x3bc;g/mL ACVM showed the strongest pro-migratory effect, although the effect declined at 100&#xa0;&#x3bc;g/mL.</p>
<p>This study is the first to evaluate the effect of ACV on keratinocyte migration. Consistent with our findings, <xref ref-type="bibr" rid="B40">Negahdari et al. (2017)</xref> reported that ACVM significantly promoted mouse dermal fibroblast migration at 50&#xa0;&#x3bc;g/mL (<xref ref-type="bibr" rid="B40">Negahdari et al., 2017</xref>). Light-enhanced cell migration can be attributed to photobiomodulation, which involves the application of low-dose visible or near-infrared light to modulate cellular activity, which has been shown to promote wound healing by stimulating keratinocyte migration, proliferation, and angiogenesis (<xref ref-type="bibr" rid="B33">Kuffler, 2016</xref>). Sutterby et al. demonstrated that orange (610&#xa0;nm, 31.12&#xa0;mJ/cm<sup>2</sup>) and red light (660&#xa0;nm, 31.36&#xa0;mJ/cm<sup>2</sup>) significantly increased HaCaT cell migration after 48&#xa0;h treatments (<xref ref-type="bibr" rid="B56">Sutterby et al., 2022</xref>). In our study, we applied a broad spectrum of visible light and observed results consistent with these findings. Furthermore, under identical light conditions, ACVM also enhanced cell migration, suggesting that the overall effects reflect a combination of ACVM activity and photobiomodulation. However, the mechanisms by which these two factors interact remain to be elucidated.</p>
<p>Representative images of cells from the control group, as well as those treated with 50&#xa0;&#x3bc;g/mL ACVM or 10&#xa0;ng/mL EGF, were captured at 0, 12, and 24&#xa0;h under dark conditions (<xref ref-type="fig" rid="F5">Figure 5</xref>) and following 30&#xa0;min light exposure (<xref ref-type="fig" rid="F6">Figure 6</xref>).</p>
<fig id="F5" position="float">
<label>FIGURE 5</label>
<caption>
<p>Representative phase-contrast images of HaCaT cells from the blank group, ACVM (50&#xa0;&#x3bc;g/mL), and EGF (10&#xa0;ng/mL) treatment groups at 0, 12, and 24&#xa0;h under dark conditions. Wound edges were outlined using yellow lines in ImageJ, and the area between the boundaries was quantified to assess cell migration. Images are representative of three independent experiments. Scale bar &#x3d; 400&#xa0;&#xb5;m.</p>
</caption>
<graphic xlink:href="fphar-16-1729572-g005.tif">
<alt-text content-type="machine-generated">Three rows of wound healing assays are shown at 0, 12, and 24-hour intervals. The top row is the control, the middle row is treated with 50 micrograms per milliliter, and the bottom row with EGF at 10 nanograms per milliliter. Yellow lines outline the wound areas, showing reduction over time, indicating cell migration.</alt-text>
</graphic>
</fig>
<fig id="F6" position="float">
<label>FIGURE 6</label>
<caption>
<p>Representative phase-contrast images of HaCaT cells from the blank group, ACVM (50&#xa0;&#x3bc;g/mL), and EGF (10&#xa0;ng/mL) treatment groups at 0, 12, and 24&#xa0;h with 30&#xa0;min light irradiation. Wound edges were outlined using yellow lines in ImageJ, and the area between the boundaries was quantified to assess cell migration. Images are representative of three independent experiments. Scale bar &#x3d; 400&#xa0;&#xb5;m.</p>
</caption>
<graphic xlink:href="fphar-16-1729572-g006.tif">
<alt-text content-type="machine-generated">Comparison of cell migration over time in a scratch assay with three conditions: control, 50 micrograms per milliliter, and epidermal growth factor (EGF) at 10 nanograms per milliliter. Images are taken at 0, 12, and 24 hours. Yellow outlines indicate wound edges. Cell migration closes gaps more in EGF-treated samples over time.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s3-6">
<label>3.6</label>
<title>Antioxidant activity of ACVM on H<sub>2</sub>O<sub>2</sub>-induced HaCaT cells</title>
<p>The effect of ACVM on H<sub>2</sub>O<sub>2</sub>-induced oxidative stress in HaCaT cells was evaluated using the DCFH-DA probe as a marker for ROS. In both the absence and presence of light (<xref ref-type="fig" rid="F7">Figure 7</xref>), exposure to H<sub>2</sub>O<sub>2</sub> resulted in a significant 1.96 &#xb1; 0.07-fold and 2.16 &#xb1; 0.06-fold increase in ROS levels compared to the untreated group (<italic>p</italic> &#x3c; 0.001), indicating the successful establishment of the oxidative stress model. The following data are presented as fold change to the H<sub>2</sub>O<sub>2</sub>-stimulated group.</p>
<fig id="F7" position="float">
<label>FIGURE 7</label>
<caption>
<p>Effect of ACVM on H<sub>2</sub>O<sub>2</sub>-induced production of ROS in HaCaT cells, with 24&#xa0;h treatment under dark condition (D) or 30&#xa0;min light exposure (L). Results are expressed as the mean &#xb1; SD of six independent measurements. <italic>p</italic> &#x3c; 0.05 (&#x2a;), <italic>p</italic> &#x3c; 0.01 (&#x2a;&#x2a;) and <italic>p</italic> &#x3c; 0.001 (&#x2a;&#x2a;&#x2a;) indicate significant differences compared to the H<sub>2</sub>O<sub>2</sub> stimulation group under dark conditions. <italic>p</italic> &#x3c; 0.05 (&#x2020;), <italic>p</italic> &#x3c; 0.01 (&#x2020;&#x2020;) and <italic>p</italic> &#x3c; 0.001 (&#x2020;&#x2020;&#x2020;) indicate significant differences compared to the H<sub>2</sub>O<sub>2</sub>stimulation group with 30&#xa0;min light exposure. <italic>p</italic> &#x3c; 0.05 (&#x23;), <italic>p</italic> &#x3c; 0.01 (&#x23;&#x23;) and <italic>p</italic> &#x3c; 0.001 (&#x23;&#x23;&#x23;) indicate significant difference between the same treatment but from two light conditions group. Data was normalized to the H<sub>2</sub>O<sub>2</sub> stimulation group, which was set as 1 and presented as the fold change.</p>
</caption>
<graphic xlink:href="fphar-16-1729572-g007.tif">
<alt-text content-type="machine-generated">Bar graph showing relative ROS levels in various conditions. Pink and blue bars represent different groups (D and L), with varying treatments: H&#x2082;O&#x2082; at 0.003%, ascorbic acid at 10 micrograms/milliliter, and ACVM at 1, 10, 50, and 100 micrograms/milliliter. Significant differences are marked with asterisks and symbols, indicating statistical relevance.</alt-text>
</graphic>
</fig>
<p>In the dark, we found that ACVM significantly suppressed H<sub>2</sub>O<sub>2</sub>-induced ROS levels in a dose-dependent manner at 50 and 100&#xa0;&#x3bc;g/mL. At both concentrations, the inhibitory effect of ACVM was comparable to that of the positive control (10&#xa0;&#x3bc;g/mL l-ascorbic acid), with no statistically significant difference observed (<xref ref-type="fig" rid="F7">Figure 7</xref>).</p>
<p>The antioxidant activity of ACV has mainly been evaluated using chemical assays. Yuan et al. reported that the ethyl acetate fraction of ACVM exhibited the strongest free radical scavenging activity at 852.5&#xa0;&#x3bc;g/mL in the DPPH assay and 28.21&#xa0;&#x3bc;g/mL in the ABTS assay (<xref ref-type="bibr" rid="B66">Yuan et al., 2012</xref>). Similarly, Rajurkar et al. found that the ethanol extract showed IC<sub>50</sub> values of 398.6&#xa0;&#x3bc;g/mL and 695&#xa0;&#x3bc;g/mL in the DPPH and ABTS assays, respectively (<xref ref-type="bibr" rid="B47">Rajurkar and Gaikwad, 2012</xref>). Seif et al. further supported its antioxidant activity <italic>in vivo</italic>, by reporting that a 50% ethanol extract (200&#xa0;mg/kg) suppressed carbendazim-induced increases in malondialdehyde (MDA) and H<sub>2</sub>O<sub>2</sub> levels in mice (<xref ref-type="bibr" rid="B53">Seif et al., 2023</xref>). Moreover, an <italic>in vitro</italic> study revealed that a 59% ethanolic extract inhibited H<sub>2</sub>O<sub>2</sub>-induced lipid peroxidation and enhanced antioxidant enzyme activities (SOD, CAT, and GPx) in human lymphocytes, although the exact concentration used was not specified (<xref ref-type="bibr" rid="B34">Kumar, 2009</xref>). The present study is the first to report on its antioxidant activity in skin cells. Based on our HPTLC data, we suggest that the high rutin and chlorogenic acid content may account for the observed antioxidant effects after H<sub>2</sub>O<sub>2</sub> challenge under dark conditions (<xref ref-type="bibr" rid="B45">Patel and Patel, 2019</xref>; <xref ref-type="bibr" rid="B41">Nguyen et al., 2024</xref>).</p>
<p>Treatment with ACVM and subsequent illumination further increased its antioxidant activity. At concentrations of 10&#xa0;&#x3bc;g/mL and 50&#xa0;&#x3bc;g/mL, ROS levels after light irradiation (0.76 &#xb1; 0.03-fold and 0.59 &#xb1; 0.02-fold, respectively) were significantly lower than those measured in the dark (0.90 &#xb1; 0.03-fold and 0.69 &#xb1; 0.10-fold, respectively). Notably, 10&#xa0;&#x3bc;g/mL of l-ascorbic acid also led to a more pronounced reduction in ROS levels under light (0.52 &#xb1; 0.06-fold) compared to darkness (0.66 &#xb1; 0.09-fold). A possible mechanism is that l-ascorbic acid undergoes photodegradation, yielding ascorbyl radicals and dehydroascorbic acid (DHA) (<xref ref-type="bibr" rid="B59">Tikekar et al., 2011</xref>). DHA enters cells more efficiently than ascorbic acid through GLUT transporters and is quickly converted back into ascorbic acid within the cell, thereby boosting intracellular vitamin C levels (<xref ref-type="bibr" rid="B63">Wilson, 2002</xref>).</p>
<p>The enhanced antioxidant activity of ACVM after light exposure may be due to photochemical transformations of the active metabolites similar to those observed for ascorbic acid. However, it cannot be ruled out that the low-dose photodynamic conditions applied to the light-sensitive molecules in the extract led to the generation of small amounts of ROS. At such low levels, ROS rather function as signaling molecules that may trigger the upregulation of antioxidant defense systems (e.g., SOD, CAT, GPx) (<xref ref-type="bibr" rid="B51">Schieber and Chandel, 2014</xref>; <xref ref-type="bibr" rid="B26">Jomova et al., 2023</xref>). Interactions with other antioxidative molecules present in our extract, such <italic>as</italic> rutin and/or chlorogenic acid, may have also contributed to the higher net antioxidative effect observed under light exposure. However, the precise mechanisms underlying this enhanced antioxidant activity require further investigation.</p>
<p>On the other hand, it is well known that chlorogenic acid contains a catechol structure that may undergo redox reactions, while rutin, a polyhydroxylated flavonoid, may cause nonspecific adsorption. Both have been classified as borderline pan-assay interfering substances (PAINS). Therefore, their presence may potentially contribute to assay-dependent artefacts or false-positive results (<xref ref-type="bibr" rid="B18">Heinrich et al., 2020</xref>; <xref ref-type="bibr" rid="B19">Heinrich et al., 2022</xref>). To address this concern, we plan to perform a series of orthogonal validation experiments to exclude such possible interferences, including (1) ROS scavenger inhibition assays (e.g., NaN<sub>3</sub>, DABCO, catalase): to verify the causal role of ROS; (2) signal interference controls using cell-free systems; and&#x2028;(3) comparison between purified fractions and the original mixture using LC-MS isolation.&#x2028;These additional experiments will help to confirm that the observed effects indeed arise from genuine photodynamic activity rather than PAINS-like chemical artefacts (<xref ref-type="bibr" rid="B18">Heinrich et al., 2020</xref>). It is also worth noting that other antioxidants present in the ACVM extract, notably chlorophylls and their derivatives, may also contribute to this activity (<xref ref-type="bibr" rid="B54">Sun et al., 2024a</xref>).</p>
</sec>
<sec id="s3-7">
<label>3.7</label>
<title>Anti-inflammatory activity of ACVM</title>
<p>Since the scratch assays and DCFH-DA tests revealed that ACVM concentrations above 50&#xa0;&#x3bc;g/mL (either under darkness or under visible-light exposure) impair cell migration-promoting and antioxidant effects, the maximum tested concentration for the anti-inflammatory assays was reduced to 50&#xa0;&#x3bc;g/mL. Prior to conducting these studies, we confirmed that, for the chosen macrophage cell line (RAW264.7), neither the proinflammatory inducer LPS (100&#xa0;ng/mL) alone, nor a combination of ACVM (0.1&#x2013;50&#xa0;&#x3bc;g/mL) and LPS (100&#xa0;ng/mL) had a significant effect on cell viability, as evaluated with the MTT assay (<xref ref-type="fig" rid="F8">Figure 8</xref>).</p>
<fig id="F8" position="float">
<label>FIGURE 8</label>
<caption>
<p>Effect of ACVM on the viability of LPS-stimulated RAW 264.7 cells after 24&#xa0;h of incubation, assessed using the MTT assay. Results are expressed as the mean &#xb1; SD from three independent experiments. <italic>p</italic> &#x3c; 0.05 (&#x2a;), <italic>p</italic> &#x3c; 0.01 (&#x2a;&#x2a;) and <italic>p</italic> &#x3c; 0.001 (&#x2a;&#x2a;&#x2a;), indicates significant differences compared to the blank group. Data were normalized to the untreated blank group, which was set as 1 and presented as the fold change.</p>
</caption>
<graphic xlink:href="fphar-16-1729572-g008.tif">
<alt-text content-type="machine-generated">Bar graph showing relative cell viability normalized to control, with LPS presence and varying ACVM concentrations. Bars represent different conditions: without LPS and ACVM, with LPS only, and with LPS plus ACVM at 0.1, 1, 10, and 50 micrograms per milliliter. Error bars indicate standard deviation. Viability ranges from 0.5 to 1.5.</alt-text>
</graphic>
</fig>
<p>The effect of ACVM on LPS-induced production of three pro-inflammatory chemokines (CXCL2, CCL2, and CXCL10) and two cytokines (IL-6 and TNF-&#x3b1;) in RAW 264.7 macrophages was evaluated using ELISA. After 24&#xa0;h of LPS stimulation, the secretion of all five inflammatory mediators increased significantly as expected, with levels exceeding a 5-fold rise relative to the untreated cells (<xref ref-type="fig" rid="F9">Figure 9</xref>). ACVM significantly and dose-dependently inhibited the production of all measured cytokines and chemokines after LPS stimulation.</p>
<fig id="F9" position="float">
<label>FIGURE 9</label>
<caption>
<p>Effect of ACVM at different concentrations on LPS-induced release of CXCL2 <bold>(A)</bold>, CCL2 <bold>(B)</bold>, CXCL10 <bold>(C)</bold>, IL-6 <bold>(D)</bold>, and TNF-a <bold>(E)</bold> in RAW 264.7 cells. Results are expressed as mean &#xb1; SD from three independent experiments and normalized to the LPS group. <italic>p</italic> &#x3c; 0.05 (&#x2a;), <italic>p</italic> &#x3c; 0.01 (&#x2a;&#x2a;), and <italic>p</italic> &#x3c; 0.001 (&#x2a;&#x2a;&#x2a;) indicate significant differences compared to LPS group.</p>
</caption>
<graphic xlink:href="fphar-16-1729572-g009.tif">
<alt-text content-type="machine-generated">Bar charts labeled A to E show the release levels of CXCL2, CCL2, CXCL10, IL-6, and TNF-&#x3B1;, respectively, normalized to LPS. Different concentrations of ACVM (0.1, 1, 10, 50 micrograms per milliliter) are compared. Asterisks indicate statistical significance. All graphs show a decrease in release with increasing ACVM concentration in the presence of LPS.</alt-text>
</graphic>
</fig>
<p>The anti-inflammatory activity of ACV has been demonstrated in multiple models. Aqueous and 80% ethanol extracts inhibited acetic acid-induced myeloperoxidase (MPO) production in rats at minimum effective doses of 300&#xa0;mg/kg and 150&#xa0;mg/kg, respectively (<xref ref-type="bibr" rid="B29">Khoramian et al., 2020</xref>). Consistently, ethyl acetate and methanol fractions, as well as isolated triterpenoids, significantly reduced carrageenan-induced edema and acetic acid&#x2013;induced writhing, supporting both extract- and compound-level efficacy (<xref ref-type="bibr" rid="B15">Haider et al., 2011</xref>; <xref ref-type="bibr" rid="B16">Haider et al., 2013</xref>). Yuan et al. reported that ethanolic extracts suppressed LPS-induced PGE<sub>2</sub> production in RAW 264.7 cells and IL-6 and TNF-&#x3b1; secretion in U937 monocytes, with IC<sub>50</sub> values &#x3c;50&#xa0;&#x3bc;g/mL. Mechanistically, this effect was mediated by inhibition of NF-&#x3ba;B activation through reduced phosphorylation of IKK&#x3b1;/&#x3b2;, p38 MAPK, and p65 (Ser536) (<xref ref-type="bibr" rid="B67">Yuan et al., 2013</xref>).</p>
<p>This study further confirmed that the methanol extracts inhibited LPS-induced production of IL-6 and TNF-&#x3b1; in a dose-dependent manner. These two cytokines are most essential and commonly used inflammatory biomarkers serving as key nodes in multiple inflammatory signaling pathways (such as NF-&#x3ba;B, JAK/STAT, and MAPK) (<xref ref-type="bibr" rid="B9">Chen et al., 2017</xref>), reflecting both the intensity and progression of inflammation. Notably, for the first time, this study identified the inhibitory effect of the extract on the release of LPS-induced chemokines (CXCL2, CCL2, and CXCL10), which play a key role in immune cell recruitment and inflammation resolution (<xref ref-type="bibr" rid="B7">Borish and Steinke, 2003</xref>). Overexpression of CXCL10 engages its receptor CXCR3, leading to the inhibition of endothelial cell proliferation, suppression of angiogenic responses, and fibroblast activity (<xref ref-type="bibr" rid="B50">Rokni et al., 2025</xref>). Elevated levels of CXCL2 promote persistent macrophage infiltration, accompanied by increased TNF-&#x3b1; production, which sustains chronic inflammation and contributes to scar formation (<xref ref-type="bibr" rid="B49">Ridiandries et al., 2018</xref>). In contrast, CCL2 generally facilitates tissue repair. Impaired CCL2 expression delays macrophage recruitment and consequently hampers the wound healing process (<xref ref-type="bibr" rid="B21">Ishida et al., 2019</xref>).</p>
<p>As anti-inflammatory tests were performed in a collaborating institution without facilities for controlling light conditions, the experiments were carried out under standard ambient light, and no comparison of light-dependent effects was possible.</p>
</sec>
</sec>
<sec id="s4">
<label>4</label>
<title>General discussion</title>
<p>This study investigated the wound-healing properties of ACV, combined with visible light phototherapy, as an innovative strategy. The findings suggest that the traditional use of ACV in wound healing is supported by its pharmacological activities, including pro-migratory, antioxidant, and anti-inflammatory effects. The introduction of visible light to the treatment protocol demonstrated significant potential for enhancing its wound healing properties.</p>
<p>Chemical analysis revealed the presence of key phytochemical chlorogenic acid, and the ability to absorb visible light, suggesting the potential of ACV for use in light-assisted therapy. However, the individual bioactivities of single compounds were not assessed in this study and are currently under investigation. Biological testing confirmed cytotoxicity and pro-migratory effects on keratinocytes, consistent with previous findings on dermal fibroblasts, thereby reinforcing the potential application of ACV in wound healing.</p>
<p>Some limitations should be acknowledged. Keratinocytes were the only skin cells used for the experiments. While keratinocytes are the primary cell type that forms the epidermal barrier, fibroblasts also play crucial roles in skin physiology and the wound-healing process. Including fibroblasts in future studies would help determine whether the observed effects are specific to keratinocytes, or represent a general cellular response in the skin. The scratch assay, although widely used and cost-effective for assessing cell migration, is sensitive to variability in wound gap uniformity due to operator technique (<xref ref-type="bibr" rid="B32">Kramer et al., 2013</xref>). To address this, future studies will employ complementary methods, such as the Boyden chamber assay, to assess and refine these findings. As the current anti-inflammatory assays did not include controlled light exposure, future work will incorporate defined light conditions, positive controls, and mechanistic analyses to more comprehensively assess the anti-inflammatory potential of ACVM.</p>
<p>This study demonstrated that light appears to enhance ACV extract activity at low concentrations. This effect diminished or even reversed at higher concentrations (e.g., 100&#xa0;&#x3bc;g/mL). Only a single light condition was tested in this study, and the homogeneity of the light source requires further improvement. Hence, it remains possible that optimizing light parameters such as wavelength, intensity, or exposure duration could improve outcomes and reduce phototoxicity. Taken together, the light-dependent changes observed in this study may arise from two complementary mechanisms. The first mechanism involves intrinsic photobiomodulation, in which visible light influences cellular behavior by altering mitochondrial function, ATP production and the overall redox state (<xref ref-type="bibr" rid="B17">Hamblin, 2018</xref>), thereby supporting proliferation, migration and inflammatory resolution. The second mechanism relates to the interaction between light and photoactive constituents within the extract to generate ROS. At low extract concentrations, the controlled ROS production stimulate pro-healing signaling, including MAPK/ERK pathways that promote migration (<xref ref-type="bibr" rid="B24">Jang et al., 2013</xref>), and Nrf2 pathways that enhance antioxidant capacity, as well as temporary reductions in inflammatory pathways such as NF-&#x3ba;B and JAK STAT (<xref ref-type="bibr" rid="B30">Khorsandi et al., 2022</xref>).</p>
<p>Although the study focused on four wound healing-related activities, it raises broader questions about the extract&#x2019;s potential in other relevant activities such as angiogenesis, extracellular matrix remodeling, and microbial defense. Whether light-assisted phototherapy is truly beneficial for wound healing depends on the results of further investigations into the combination of light and extracts on these biological activities. Targeted studies are needed to determine how light influences each process and whether its integration can reliably enhance therapeutic efficacy.</p>
</sec>
<sec sec-type="conclusion" id="s5">
<label>5</label>
<title>Conclusion</title>
<p>Collectively, our results demonstrate the feasibility of integrating plant-derived medicines with modern scientific technologies. This aligns with the goals of the WHO&#x2019;s Traditional Medicine Strategy 2025&#x2013;2034 by contributing rigorous, relevant research that could lead to more efficient and safer uses of medicinal plants (i.e., traditional medicine) and natural products in wound care. Although wound healing is one aspect of skin-related disorders, the bioactivities observed in this study may also be applicable to other dermatological conditions, suggesting a broader therapeutic potential for the investigated plant species. Moreover, these results reaffirm the remarkable potential of plant-based medicines in disease treatment. Moving forward, ensuring their safe and effective application and sustainable development remains a shared challenge among researchers and practitioners in this field, as well as a primary focus for our future work.</p>
</sec>
</body>
<back>
<sec sec-type="data-availability" id="s6">
<title>Data availability statement</title>
<p>The original contributions presented in the study are included in the article/<xref ref-type="sec" rid="s13">Supplementary Material</xref>, further inquiries can be directed to the corresponding author.</p>
</sec>
<sec sec-type="ethics-statement" id="s7">
<title>Ethics statement</title>
<p>Ethical approval was not required for the studies on humans in accordance with the local legislation and institutional requirements because only commercially available established cell lines were used. Ethical approval was not required for the studies on animals in accordance with the local legislation and institutional requirements because only commercially available established cell lines were used.</p>
</sec>
<sec sec-type="author-contributions" id="s8">
<title>Author contributions</title>
<p>LM: Writing &#x2013; original draft, Writing &#x2013; review and editing, Conceptualization, Data curation, Formal Analysis, Investigation, Methodology, Software, Visualization. BJ: Writing &#x2013; review and editing. FS: Writing &#x2013; review and editing, Conceptualization. ML: Writing &#x2013; review and editing. BF: Writing &#x2013; review and editing. LS: Writing &#x2013; review and editing. CM: Writing &#x2013; review and editing, Conceptualization, Funding acquisition. MH: Writing &#x2013; review and editing, Conceptualization, Funding acquisition, Supervision.</p>
</sec>
<ack>
<title>Acknowledgements</title>
<p>We wound like to express sincere gratitude to the foundation VELUX STIFTUNG for their generous financial support, which made this research possible.</p>
</ack>
<sec sec-type="COI-statement" id="s10">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
<p>The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.</p>
</sec>
<sec sec-type="ai-statement" id="s11">
<title>Generative AI statement</title>
<p>The authors declare that no Generative AI was used in the creation of this manuscript.</p>
<p>Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.</p>
</sec>
<sec sec-type="disclaimer" id="s12">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec sec-type="supplementary-material" id="s13">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fphar.2025.1729572/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fphar.2025.1729572/full&#x23;supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="Supplementaryfile1.docx" id="SM1" mimetype="application/docx" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<fn-group>
<fn fn-type="custom" custom-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/521196/overview">Patricia Rijo</ext-link>, Lusofona University, Portugal</p>
</fn>
<fn fn-type="custom" custom-type="reviewed-by">
<p>
<bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/275593/overview">Abdullah Shaito</ext-link>, Qatar University, Qatar</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/770719/overview">Carsten Gr&#xfc;ndemann</ext-link>, University of Basel, Switzerland</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/2286432/overview">Francisco Cruz-Sosa</ext-link>, Universidad Aut&#xf3;noma Metropolitana, Mexico</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="B1">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Al-Ghanayem</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Sanad Alhussaini</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Abdulla Ibrahim Alyahya</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Asad</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Joseph</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Abdulrahman Al-Ghanayem</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2024</year>). <article-title>Wound healing activity of chlorogenic acid in diabetic rats is mediated through antibacterial, antioxidant, and proliferative effects</article-title>. <source>OnLine J. Biol. Sci. Orig. Res. Pap.</source> <volume>24</volume>, <fpage>255</fpage>&#x2013;<lpage>262</lpage>. <pub-id pub-id-type="doi">10.3844/ojbsci.2024.255.262</pub-id>
</mixed-citation>
</ref>
<ref id="B2">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Al-Khesraji</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Maulood</surname>
<given-names>B. K.</given-names>
</name>
<name>
<surname>K.</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Flavonoid contents of Adiantum capillus-veneris L. growing in two different districts from Iraqi Kurdistan Northern Iraq</article-title>. <source>Egypt. Acad. J. Biol. Sci. H. Bot. ISSN</source> <volume>8</volume>, <fpage>25</fpage>&#x2013;<lpage>31</lpage>. <pub-id pub-id-type="doi">10.21608/eajbsh.2017.16815</pub-id>
</mixed-citation>
</ref>
<ref id="B3">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Almeida</surname>
<given-names>J. S.</given-names>
</name>
<name>
<surname>Benvegn&#xfa;</surname>
<given-names>D. M.</given-names>
</name>
<name>
<surname>Boufleur</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Reckziegel</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Barcelos</surname>
<given-names>R. C. S.</given-names>
</name>
<name>
<surname>Coradini</surname>
<given-names>K.</given-names>
</name>
<etal/>
</person-group> (<year>2012</year>). <article-title>Hydrogels containing rutin intended for cutaneous administration: efficacy in wound healing in rats</article-title>. <source>Drug Dev. Ind. Pharm.</source> <volume>38</volume>, <fpage>792</fpage>&#x2013;<lpage>799</lpage>. <pub-id pub-id-type="doi">10.3109/03639045.2011.628676</pub-id>
<pub-id pub-id-type="pmid">22066462</pub-id>
</mixed-citation>
</ref>
<ref id="B4">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ansari</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Ekhlasi-Kazaj</surname>
<given-names>K.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Adiantum capillus-veneris. L: phytochemical constituents, traditional uses and pharmacological properties: a review</article-title>. <source>J. Adv. Sci. Res.</source> <volume>3</volume>, <fpage>15</fpage>&#x2013;<lpage>20</lpage>. <comment>Available online at: <ext-link ext-link-type="uri" xlink:href="https://sciensage.info/index.php/JASR/article/view/124">https://sciensage.info/index.php/JASR/article/view/124</ext-link>.</comment>
</mixed-citation>
</ref>
<ref id="B5">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Basri</surname>
<given-names>D. F.</given-names>
</name>
<name>
<surname>Nor</surname>
<given-names>N. H. M.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Phytoconstituent screening and antibacterial activity of the leaf extracts from Canarium odontophyllum Miq</article-title>. <source>Am. J. Plant Sci.</source> <volume>5</volume>, <fpage>2878</fpage>&#x2013;<lpage>2888</lpage>. <pub-id pub-id-type="doi">10.4236/ajps.2014.519303</pub-id>
</mixed-citation>
</ref>
<ref id="B6">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bhattacharyya</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Majhi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Saha</surname>
<given-names>B. P.</given-names>
</name>
<name>
<surname>Mukherjee</surname>
<given-names>P. K.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Chlorogenic acid&#x2013;phospholipid complex improve protection against UVA induced oxidative stress</article-title>. <source>J. Photochem. Photobiol. B Biol.</source> <volume>130</volume>, <fpage>293</fpage>&#x2013;<lpage>298</lpage>. <pub-id pub-id-type="doi">10.1016/j.jphotobiol.2013.11.020</pub-id>
<pub-id pub-id-type="pmid">24378330</pub-id>
</mixed-citation>
</ref>
<ref id="B7">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Borish</surname>
<given-names>L. C.</given-names>
</name>
<name>
<surname>Steinke</surname>
<given-names>J. W.</given-names>
</name>
</person-group> (<year>2003</year>). <article-title>2. Cytokines and chemokines</article-title>. <source>J. Allergy Clin. Immunol.</source> <volume>111</volume>, <fpage>S460</fpage>&#x2013;<lpage>S475</lpage>. <pub-id pub-id-type="doi">10.1067/mai.2003.108</pub-id>
<pub-id pub-id-type="pmid">12592293</pub-id>
</mixed-citation>
</ref>
<ref id="B8">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>W. C.</given-names>
</name>
<name>
<surname>Liou</surname>
<given-names>S. S.</given-names>
</name>
<name>
<surname>Tzeng</surname>
<given-names>T. F.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>S. L.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>I. M.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Effect of topical application of chlorogenic acid on excision wound healing in rats</article-title>. <source>Planta Med.</source> <volume>79</volume>, <fpage>616</fpage>&#x2013;<lpage>621</lpage>. <pub-id pub-id-type="doi">10.1055/s-0032-1328364</pub-id>
<pub-id pub-id-type="pmid">23568627</pub-id>
</mixed-citation>
</ref>
<ref id="B9">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Deng</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Cui</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Fang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zuo</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Deng</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Inflammatory responses and inflammation-associated diseases in organs</article-title>. <source>Oncotarget</source> <volume>9</volume>, <fpage>7204</fpage>&#x2013;<lpage>7218</lpage>. <pub-id pub-id-type="doi">10.18632/oncotarget.23208</pub-id>
<pub-id pub-id-type="pmid">29467962</pub-id>
</mixed-citation>
</ref>
<ref id="B10">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>L. Y.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>C. N.</given-names>
</name>
<name>
<surname>Liao</surname>
<given-names>C. K.</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>H. M.</given-names>
</name>
<name>
<surname>Kuan</surname>
<given-names>Y. H.</given-names>
</name>
<name>
<surname>Tseng</surname>
<given-names>T. J.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Effects of rutin on wound healing in hyperglycemic rats</article-title>. <source>Antioxidants</source> <volume>9</volume>, <fpage>1</fpage>&#x2013;<lpage>13</lpage>. <pub-id pub-id-type="doi">10.3390/antiox9111122</pub-id>
<pub-id pub-id-type="pmid">33202817</pub-id>
</mixed-citation>
</ref>
<ref id="B11">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Choi</surname>
<given-names>K. S.</given-names>
</name>
<name>
<surname>Kundu</surname>
<given-names>J. K.</given-names>
</name>
<name>
<surname>Chun</surname>
<given-names>K. S.</given-names>
</name>
<name>
<surname>Na</surname>
<given-names>H. K.</given-names>
</name>
<name>
<surname>Surh</surname>
<given-names>Y. J.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Rutin inhibits UVB radiation-induced expression of COX-2 and iNOS in hairless mouse skin: P38 MAP kinase and JNK as potential targets</article-title>. <source>Arch. Biochem. Biophys.</source> <volume>559</volume>, <fpage>38</fpage>&#x2013;<lpage>45</lpage>. <pub-id pub-id-type="doi">10.1016/j.abb.2014.05.016</pub-id>
<pub-id pub-id-type="pmid">24875145</pub-id>
</mixed-citation>
</ref>
<ref id="B12">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dehdari</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Hajimehdipoor</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Medicinal properties of Adiantum capillus-veneris Linn. in traditional medicine and modern phytotherapy: a review article. in Traditional Medicine and Modern Phytotherapy: A Review Article</article-title>. <source>Iran. J. Public Health</source> <volume>47</volume>, <fpage>188</fpage>&#x2013;<lpage>197</lpage>. <comment>Available online at: <ext-link ext-link-type="uri" xlink:href="https://pmc.ncbi.nlm.nih.gov/articles/PMC5810381/">https://pmc.ncbi.nlm.nih.gov/articles/PMC5810381/</ext-link>
</comment>
<pub-id pub-id-type="pmid">29445628</pub-id>
</mixed-citation>
</ref>
<ref id="B13">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ennis</surname>
<given-names>W. J.</given-names>
</name>
<name>
<surname>Hill</surname>
<given-names>D.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Wound healing: a comprehensive wound assessment and treatment approach</article-title>. <source>Ski. Tissue Eng. Regen. Med.</source>, <fpage>239</fpage>&#x2013;<lpage>263</lpage>. <pub-id pub-id-type="doi">10.1016/b978-0-12-801654-1.00012-7</pub-id>
</mixed-citation>
</ref>
<ref id="B14">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Galehdari</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Negahdari</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kesmati</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Rezaie</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Shariati</surname>
<given-names>G.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Effect of the herbal mixture composed of Aloe vera, Henna, Adiantum capillus-veneris, and Myrrha on wound healing in streptozotocin-induced diabetic rats</article-title>. <source>BMC Complement. Altern. Med.</source> <volume>16</volume>, <fpage>386</fpage>&#x2013;<lpage>389</lpage>. <pub-id pub-id-type="doi">10.1186/s12906-016-1359-7</pub-id>
<pub-id pub-id-type="pmid">27716154</pub-id>
</mixed-citation>
</ref>
<ref id="B15">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Haider</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Nazreen</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Alam</surname>
<given-names>M. M.</given-names>
</name>
<name>
<surname>Gupta</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Hamid</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Alam</surname>
<given-names>M. S.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Anti-inflammatory and anti-nociceptive activities of ethanolic extract and its various fractions from Adiantum capillus veneris Linn</article-title>. <source>J. Ethnopharmacol.</source> <volume>138</volume>, <fpage>741</fpage>&#x2013;<lpage>747</lpage>. <pub-id pub-id-type="doi">10.1016/j.jep.2011.10.012</pub-id>
<pub-id pub-id-type="pmid">22020277</pub-id>
</mixed-citation>
</ref>
<ref id="B16">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Haider</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kharbanda</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Alam</surname>
<given-names>M. S.</given-names>
</name>
<name>
<surname>Hamid</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Ali</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Alam</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2013</year>). <article-title>Anti-inflammatory and anti-nociceptive activities of two new triterpenoids from Adiantum capillus-veneris Linn</article-title>. <source>Nat. Prod. Res.</source> <volume>27</volume>, <fpage>2304</fpage>&#x2013;<lpage>2310</lpage>. <pub-id pub-id-type="doi">10.1080/14786419.2013.828292</pub-id>
<pub-id pub-id-type="pmid">23972143</pub-id>
</mixed-citation>
</ref>
<ref id="B17">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hamblin</surname>
<given-names>M. R.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Mechanisms and mitochondrial redox signaling in photobiomodulation</article-title>. <source>Photochem. Photobiol.</source> <volume>94</volume>, <fpage>199</fpage>&#x2013;<lpage>212</lpage>. <pub-id pub-id-type="doi">10.1111/php.12864</pub-id>
<pub-id pub-id-type="pmid">29164625</pub-id>
</mixed-citation>
</ref>
<ref id="B18">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Heinrich</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Appendino</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Efferth</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>F&#xfc;rst</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Izzo</surname>
<given-names>A. A.</given-names>
</name>
<name>
<surname>Kayser</surname>
<given-names>O.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Best practice in research &#x2013; overcoming common challenges in phytopharmacological research</article-title>. <source>J. Ethnopharmacol.</source> <volume>246</volume>, <fpage>112230</fpage>. <pub-id pub-id-type="doi">10.1016/j.jep.2019.112230</pub-id>
<pub-id pub-id-type="pmid">31526860</pub-id>
</mixed-citation>
</ref>
<ref id="B19">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Heinrich</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Jalil</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Abdel-Tawab</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Echeverria</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Kuli&#x107;</surname>
<given-names>&#x17d;.</given-names>
</name>
<name>
<surname>McGaw</surname>
<given-names>L. J.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Best practice in the chemical characterisation of extracts used in pharmacological and toxicological research-The ConPhyMP-Guidelines</article-title>. <source>Front. Pharmacol.</source> <volume>13</volume>, <fpage>953205</fpage>. <pub-id pub-id-type="doi">10.3389/fphar.2022.953205</pub-id>
<pub-id pub-id-type="pmid">36176427</pub-id>
</mixed-citation>
</ref>
<ref id="B20">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hoenders</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Ghelman</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Portella</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Simmons</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Locke</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Cramer</surname>
<given-names>H.</given-names>
</name>
<etal/>
</person-group> (<year>2024</year>). <article-title>A review of the WHO strategy on traditional, complementary, and integrative medicine from the perspective of academic consortia for integrative medicine and health</article-title>. <source>Front. Med.</source> <volume>11</volume>, <fpage>1395698</fpage>. <pub-id pub-id-type="doi">10.3389/fmed.2024.1395698</pub-id>
<pub-id pub-id-type="pmid">38933107</pub-id>
</mixed-citation>
</ref>
<ref id="B21">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ishida</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Kuninaka</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Nosaka</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Furuta</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kimura</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Taruya</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>CCL2-Mediated reversal of impaired skin wound healing in diabetic mice by normalization of neovascularization and collagen accumulation</article-title>. <source>J. Invest. Dermatol.</source> <volume>139</volume>, <fpage>2517</fpage>&#x2013;<lpage>2527.e5</lpage>. <pub-id pub-id-type="doi">10.1016/j.jid.2019.05.022</pub-id>
<pub-id pub-id-type="pmid">31247201</pub-id>
</mixed-citation>
</ref>
<ref id="B22">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jaafer</surname>
<given-names>M. F.</given-names>
</name>
<name>
<surname>Mahood</surname>
<given-names>W. S.</given-names>
</name>
<name>
<surname>Alyami</surname>
<given-names>M. S. S.</given-names>
</name>
</person-group> (<year>2025</year>). <article-title>Adiantum capillus-veneris L.: a comprehensive review of its phytochemical composition, pharmacological activities, and therapeutic potential</article-title>. <source>Baghdad J. biochem. Appl. Biol. Sci.</source> <volume>6</volume>, <fpage>85</fpage>&#x2013;<lpage>99</lpage>. <pub-id pub-id-type="doi">10.47419/bjbabs.v6i2.343</pub-id>
</mixed-citation>
</ref>
<ref id="B23">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jain</surname>
<given-names>S. K.</given-names>
</name>
<name>
<surname>Singh</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Pande</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Nema</surname>
<given-names>N.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Neuropharmacological screening of fronds of Adiantum capillus veneris linn</article-title>. <source>Der Pharm. Lett.</source> <volume>6</volume>, <fpage>167</fpage>&#x2013;<lpage>175</lpage>. <comment>Available online at: <ext-link ext-link-type="uri" xlink:href="https://www.scholarsresearchlibrary.com/articles/neuropharmacological-screening-of-fronds-of-adiantum-capillus-veneris-linn.pdf">https://www.scholarsresearchlibrary.com/articles/neuropharmacological-screening-of-fronds-of-adiantum-capillus-veneris-linn.pdf</ext-link>.</comment>
</mixed-citation>
</ref>
<ref id="B24">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jang</surname>
<given-names>Y. H.</given-names>
</name>
<name>
<surname>Koo</surname>
<given-names>G. B.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>J. Y.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>Y. S.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>Y. C.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Prolonged activation of ERK contributes to the photorejuvenation effect in photodynamic therapy in human dermal fibroblasts</article-title>. <source>J. Invest. Dermatol.</source> <volume>133</volume>, <fpage>2265</fpage>&#x2013;<lpage>2275</lpage>. <pub-id pub-id-type="doi">10.1038/jid.2013.25</pub-id>
<pub-id pub-id-type="pmid">23337889</pub-id>
</mixed-citation>
</ref>
<ref id="B25">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jiang</surname>
<given-names>M. Z.</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Wen</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X. M.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>
<italic>In vitro</italic> and <italic>in vivo</italic> studies of antioxidant activities of flavonoids from Adiantum capillus-veneris L</article-title>. <source>Afr. J. Pharm. Pharmacol.</source> <volume>5</volume>, <fpage>2079</fpage>&#x2013;<lpage>2085</lpage>. <pub-id pub-id-type="doi">10.5897/ajpp11.500</pub-id>
</mixed-citation>
</ref>
<ref id="B26">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jomova</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Raptova</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Alomar</surname>
<given-names>S. Y.</given-names>
</name>
<name>
<surname>Alwasel</surname>
<given-names>S. H.</given-names>
</name>
<name>
<surname>Nepovimova</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Kuca</surname>
<given-names>K.</given-names>
</name>
<etal/>
</person-group> (<year>2023</year>). <article-title>Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging</article-title>. <source>Arch. Toxicol.</source> <volume>97</volume>, <fpage>2499</fpage>&#x2013;<lpage>2574</lpage>. <pub-id pub-id-type="doi">10.1007/s00204-023-03562-9</pub-id>
<pub-id pub-id-type="pmid">37597078</pub-id>
</mixed-citation>
</ref>
<ref id="B27">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kang</surname>
<given-names>Y. R.</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Jung</surname>
<given-names>S. K.</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>Y. H.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Synthesis, characterization, and functional properties of chlorophylls, pheophytins, and Zn-pheophytins</article-title>. <source>Food Chem.</source> <volume>245</volume>, <fpage>943</fpage>&#x2013;<lpage>950</lpage>. <pub-id pub-id-type="doi">10.1016/j.foodchem.2017.11.079</pub-id>
<pub-id pub-id-type="pmid">29287463</pub-id>
</mixed-citation>
</ref>
<ref id="B28">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Khan</surname>
<given-names>M. F.</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Lyles</surname>
<given-names>J. T.</given-names>
</name>
<name>
<surname>Pineau</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Mashwani</surname>
<given-names>Z. ur R.</given-names>
</name>
<name>
<surname>Quave</surname>
<given-names>C. L.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Antibacterial properties of medicinal plants from Pakistan against multidrug-resistant ESKAPE pathogens</article-title>. <source>Front. Pharmacol.</source> <volume>9</volume>, <fpage>815</fpage>. <pub-id pub-id-type="doi">10.3389/fphar.2018.00815</pub-id>
<pub-id pub-id-type="pmid">30116190</pub-id>
</mixed-citation>
</ref>
<ref id="B29">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Khoramian</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Sajjadi</surname>
<given-names>S.-E.</given-names>
</name>
<name>
<surname>Minaiyan</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Anti-inflammatory effect of Adiantum capillus-veneris hydroalcoholic and aqueous extracts on acetic acid-induced colitis in rats</article-title>. <source>Avicenna J. Phytomedicine</source> <volume>10</volume>, <fpage>492</fpage>&#x2013;<lpage>503</lpage>. <comment>Available online at: <ext-link ext-link-type="uri" xlink:href="https://pmc.ncbi.nlm.nih.gov/articles/PMC7508316/">https://pmc.ncbi.nlm.nih.gov/articles/PMC7508316/</ext-link>.</comment>
<pub-id pub-id-type="pmid">32995327</pub-id>
</mixed-citation>
</ref>
<ref id="B30">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Khorsandi</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Hosseinzadeh</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Esfahani</surname>
<given-names>H. S.</given-names>
</name>
<name>
<surname>Zandsalimi</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Shahidi</surname>
<given-names>F. K.</given-names>
</name>
<name>
<surname>Abrahamse</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Accelerating skin regeneration and wound healing by controlled ROS from photodynamic treatment</article-title>. <source>Inflamm. Regen.</source> <volume>42</volume>, <fpage>40</fpage>. <pub-id pub-id-type="doi">10.1186/s41232-022-00226-6</pub-id>
<pub-id pub-id-type="pmid">36192814</pub-id>
</mixed-citation>
</ref>
<ref id="B31">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kang</surname>
<given-names>M. C.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>H. H. L.</given-names>
</name>
<name>
<surname>Cho</surname>
<given-names>C. H.</given-names>
</name>
<name>
<surname>Choi</surname>
<given-names>I.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Antioxidant effects of turmeric leaf extract against hydrogen peroxide-induced oxidative stress <italic>in vitro</italic> in vero cells and <italic>in vivo</italic> in zebrafish</article-title>. <source>Antioxidants (Basel, Switzerland)</source> <volume>10</volume>, <fpage>112</fpage>&#x2013;<lpage>114</lpage>. <pub-id pub-id-type="doi">10.3390/antiox10010112</pub-id>
<pub-id pub-id-type="pmid">33466809</pub-id>
</mixed-citation>
</ref>
<ref id="B32">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kramer</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Walzl</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Unger</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Rosner</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Krupitza</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Hengstschl&#xe4;ger</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2013</year>). <article-title>
<italic>In vitro</italic> cell migration and invasion assays</article-title>. <source>Mutat. Res. Mutat. Res.</source> <volume>752</volume>, <fpage>10</fpage>&#x2013;<lpage>24</lpage>. <pub-id pub-id-type="doi">10.1016/j.mrrev.2012.08.001</pub-id>
<pub-id pub-id-type="pmid">22940039</pub-id>
</mixed-citation>
</ref>
<ref id="B33">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kuffler</surname>
<given-names>D. P.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Photobiomodulation in promoting wound healing: a review</article-title>. <source>Regen. Med.</source> <volume>11</volume>, <fpage>107</fpage>&#x2013;<lpage>122</lpage>. <pub-id pub-id-type="doi">10.2217/rme.15.82</pub-id>
<pub-id pub-id-type="pmid">26681143</pub-id>
</mixed-citation>
</ref>
<ref id="B34">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kumar</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Antioxidant effect of Adiantum capillus-veneris linn. on human lymphocyte: an <italic>in vitro</italic> study</article-title>. <source>J. Cell Tissue Res.</source> <volume>9</volume>, <fpage>1899</fpage>&#x2013;<lpage>1902</lpage>. <comment>Available online at: <ext-link ext-link-type="uri" xlink:href="https://www.tcrjournals.com/uploads/6880820_Anil.pdf">https://www.tcrjournals.com/uploads/6880820_Anil.pdf</ext-link>.</comment>
</mixed-citation>
</ref>
<ref id="B35">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kumar Sagar</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Alam</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Sajwan</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Khan</surname>
<given-names>A. S.</given-names>
</name>
<name>
<surname>Meena</surname>
<given-names>R. P.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>HPTLC finger printing studies and evaluation of pharmacopoeial standards for the medicinal plant Adiantum capillus-veneris L</article-title>. <source>Int. J. Sci. Res. Chem.</source> <volume>7</volume>. <fpage>01</fpage>&#x2013;<lpage>15</lpage>. <comment>Available online at: <ext-link ext-link-type="uri" xlink:href="https://ijsrch.com/IJSRCH21657">https://ijsrch.com/IJSRCH21657</ext-link>.</comment>
</mixed-citation>
</ref>
<ref id="B36">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liang</surname>
<given-names>C. C.</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>A. Y.</given-names>
</name>
<name>
<surname>Guan</surname>
<given-names>J. L.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>
<italic>In vitro</italic> scratch assay: a convenient and inexpensive method for analysis of cell migration <italic>in vitro</italic>
</article-title>. <source>Nat. Protoc.</source> <volume>2</volume>, <fpage>329</fpage>&#x2013;<lpage>333</lpage>. <pub-id pub-id-type="doi">10.1038/nprot.2007.30</pub-id>
<pub-id pub-id-type="pmid">17406593</pub-id>
</mixed-citation>
</ref>
<ref id="B37">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mallidi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Anbil</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Bulin</surname>
<given-names>A. L.</given-names>
</name>
<name>
<surname>Obaid</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Ichikawa</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Hasan</surname>
<given-names>T.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Beyond the barriers of light penetration: strategies, perspectives and possibilities for photodynamic therapy</article-title>. <source>Theranostics</source> <volume>6</volume>, <fpage>2458</fpage>&#x2013;<lpage>2487</lpage>. <pub-id pub-id-type="doi">10.7150/thno.16183</pub-id>
<pub-id pub-id-type="pmid">27877247</pub-id>
</mixed-citation>
</ref>
<ref id="B38">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mikzi&#x144;ski</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Kraus</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Seredy&#x144;ski</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Widelski</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Paluch</surname>
<given-names>E.</given-names>
</name>
</person-group> (<year>2025</year>). <article-title>Photocatalysis and photodynamic therapy in diabetic foot ulcers (DFUs) care: a novel approach to infection control and tissue regeneration</article-title>. <source>Mol</source> <volume>30</volume>, <fpage>2323</fpage>&#x2013;<lpage>2330</lpage>. <pub-id pub-id-type="doi">10.3390/molecules30112323</pub-id>
<pub-id pub-id-type="pmid">40509211</pub-id>
</mixed-citation>
</ref>
<ref id="B39">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Monika</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Chandraprabha</surname>
<given-names>M. N.</given-names>
</name>
<name>
<surname>Rangarajan</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Waiker</surname>
<given-names>P. V.</given-names>
</name>
<name>
<surname>Chidambara Murthy</surname>
<given-names>K. N.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Challenges in healing wound: role of complementary and alternative medicine</article-title>. <source>Front. Nutr.</source> <volume>8</volume>, <fpage>791899</fpage>. <pub-id pub-id-type="doi">10.3389/fnut.2021.791899</pub-id>
<pub-id pub-id-type="pmid">35127787</pub-id>
</mixed-citation>
</ref>
<ref id="B40">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Negahdari</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Galehdari</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Kesmati</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Rezaie</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Shariati</surname>
<given-names>G.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Wound healing activity of extracts and formulations of Aloe vera, Henna, Adiantum capillus-veneris, and myrrh on mouse dermal fibroblast cells</article-title>. <source>Int. J. Prev. Med.</source> <volume>8</volume>, <fpage>18</fpage>. <pub-id pub-id-type="doi">10.4103/ijpvm.ijpvm_338_16</pub-id>
<pub-id pub-id-type="pmid">28382194</pub-id>
</mixed-citation>
</ref>
<ref id="B41">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nguyen</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Taine</surname>
<given-names>E. G.</given-names>
</name>
<name>
<surname>Meng</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Cui</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Tan</surname>
<given-names>W.</given-names>
</name>
</person-group> (<year>2024</year>). <article-title>Chlorogenic acid: a systematic review on the biological functions, mechanistic actions, and therapeutic potentials</article-title>. <source>Nutrients</source> <volume>16</volume>, <fpage>924</fpage>. <pub-id pub-id-type="doi">10.3390/nu16070924</pub-id>
<pub-id pub-id-type="pmid">38612964</pub-id>
</mixed-citation>
</ref>
<ref id="B42">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nilforoushzadeh</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>Javanmard</surname>
<given-names>S. H.</given-names>
</name>
<name>
<surname>Ghanadian</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Asghari</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Jaffary</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Yakhdani</surname>
<given-names>A. F.</given-names>
</name>
<etal/>
</person-group> (<year>2014</year>). <article-title>The effects of Adiantum capillus-veneris on wound healing: an experimental <italic>in vitro</italic> evaluation</article-title>. <source>Int. J. Prev. Med.</source> <volume>5</volume>, <fpage>1261</fpage>&#x2013;<lpage>1268</lpage>. <comment>Available online at: <ext-link ext-link-type="uri" xlink:href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4223945/">https://pmc.ncbi.nlm.nih.gov/articles/PMC4223945/</ext-link>.</comment>
<pub-id pub-id-type="pmid">25400884</pub-id>
</mixed-citation>
</ref>
<ref id="B43">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Osman Mahmud</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Abdulqader Amin</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Abdullah Alshawsh</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Mahmud</surname>
<given-names>S. O.</given-names>
</name>
<name>
<surname>Amin</surname>
<given-names>Z. A.</given-names>
</name>
<name>
<surname>Nuraddin</surname>
<given-names>S. M.</given-names>
</name>
<etal/>
</person-group> (<year>2023</year>). <article-title>Antioxidant and wound healing properties of Prosopis farcta and Adiantum capillus plant extracts: an <italic>in vitro</italic> study</article-title>. <source>J. Pharm. Negat. Results</source> <volume>14</volume>, <fpage>3831</fpage>&#x2013;<lpage>3839</lpage>. <pub-id pub-id-type="doi">10.47750/pnr.2023.14.03.480</pub-id>
</mixed-citation>
</ref>
<ref id="B44">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Papa</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Furci</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Minciullo</surname>
<given-names>P. L.</given-names>
</name>
<name>
<surname>Casciaro</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Allegra</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Gangemi</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2025</year>). <article-title>Photodynamic therapy in cancer: insights into cellular and molecular pathways</article-title>. <source>Curr. Issues Mol. Biol.</source> <volume>47</volume>, <fpage>47</fpage>&#x2013;<lpage>69</lpage>. <pub-id pub-id-type="doi">10.3390/cimb47020069</pub-id>
<pub-id pub-id-type="pmid">39996790</pub-id>
</mixed-citation>
</ref>
<ref id="B45">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Patel</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Patel</surname>
<given-names>D. K.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>The beneficial role of rutin, A naturally occurring flavonoid in health promotion and disease prevention: a systematic review and update</article-title>. <source>Bioact. Food as Diet. Interv. Arthritis Relat. Inflamm. Dis.</source>, <fpage>457</fpage>&#x2013;<lpage>479</lpage>. <pub-id pub-id-type="doi">10.1016/b978-0-12-813820-5.00026-x</pub-id>
</mixed-citation>
</ref>
<ref id="B46">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Qadir</surname>
<given-names>S. A.</given-names>
</name>
<name>
<surname>Awlqadr</surname>
<given-names>F. H.</given-names>
</name>
<name>
<surname>Qadir</surname>
<given-names>M. H.</given-names>
</name>
<name>
<surname>Qadir</surname>
<given-names>A. M.</given-names>
</name>
<name>
<surname>Faraj</surname>
<given-names>A. M.</given-names>
</name>
<name>
<surname>Salih</surname>
<given-names>S. A.</given-names>
</name>
<etal/>
</person-group> (<year>2025</year>). <article-title>Adiantum capillus-veneris: a comprehensive review of its medicinal properties, bioactive compounds, and advanced extraction techniques</article-title>. <source>Food Sci. Nutr.</source> <volume>13</volume>, <fpage>e71118</fpage>. <pub-id pub-id-type="doi">10.1002/fsn3.71118</pub-id>
<pub-id pub-id-type="pmid">41132578</pub-id>
</mixed-citation>
</ref>
<ref id="B47">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rajurkar</surname>
<given-names>N. S.</given-names>
</name>
<name>
<surname>Gaikwad</surname>
<given-names>K.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Evaluation of phytochemicals, antioxidant activity and elemental content of Adiantum capillus veneris leaves</article-title>. <source>J. Chem. Pharm. Res.</source> <volume>4</volume>, <fpage>365</fpage>&#x2013;<lpage>374</lpage>. <comment>Available online at: <ext-link ext-link-type="uri" xlink:href="http://jocpr.com/vol4-iss1-2012/JCPR-2012-4-1-365-374.pdf">http://jocpr.com/vol4-iss1-2012/JCPR-2012-4-1-365-374.pdf</ext-link>.</comment>
</mixed-citation>
</ref>
<ref id="B48">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rastogi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Pandey</surname>
<given-names>M. M.</given-names>
</name>
<name>
<surname>Rawat</surname>
<given-names>A. K. S.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Ethnopharmacological uses, phytochemistry and pharmacology of genus adiantum: a comprehensive review</article-title>. <source>J. Ethnopharmacol.</source> <volume>215</volume>, <fpage>101</fpage>&#x2013;<lpage>119</lpage>. <pub-id pub-id-type="doi">10.1016/j.jep.2017.12.034</pub-id>
<pub-id pub-id-type="pmid">29288826</pub-id>
</mixed-citation>
</ref>
<ref id="B49">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ridiandries</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Tan</surname>
<given-names>J. T. M.</given-names>
</name>
<name>
<surname>Bursill</surname>
<given-names>C. A.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>The role of chemokines in wound healing</article-title>. <source>Int. J. Mol. Sci.</source> <volume>19</volume>, <fpage>3217</fpage>. <pub-id pub-id-type="doi">10.3390/ijms19103217</pub-id>
<pub-id pub-id-type="pmid">30340330</pub-id>
</mixed-citation>
</ref>
<ref id="B50">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rokni</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Khomeijani-Farahani</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Soltani</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Jamshidi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Mahmoudi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Farhadi</surname>
<given-names>E.</given-names>
</name>
</person-group> (<year>2025</year>). <article-title>Understanding the pleiotropic effects of CXCL10/IP-10 in the immunopathogenesis of inflammatory rheumatic diseases: implications for better understanding disease mechanisms</article-title>. <source>Int. Immunopharmacol.</source> <volume>153</volume>, <fpage>114456</fpage>. <pub-id pub-id-type="doi">10.1016/j.intimp.2025.114456</pub-id>
<pub-id pub-id-type="pmid">40121742</pub-id>
</mixed-citation>
</ref>
<ref id="B51">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schieber</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Chandel</surname>
<given-names>N. S.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>ROS function in redox signaling and oxidative stress</article-title>. <source>Curr. Biol.</source> <volume>24</volume>, <fpage>R453</fpage>&#x2013;<lpage>R462</lpage>. <pub-id pub-id-type="doi">10.1016/j.cub.2014.03.034</pub-id>
<pub-id pub-id-type="pmid">24845678</pub-id>
</mixed-citation>
</ref>
<ref id="B52">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Scotti</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Mou</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Booker</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Weckerle</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Maake</surname>
<given-names>C.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Treating chronic wounds using photoactive metabolites: data mining the Chinese pharmacopoeia for potential lead species</article-title>. <source>Planta Med.</source> <volume>87</volume>, <fpage>1206</fpage>&#x2013;<lpage>1218</lpage>. <pub-id pub-id-type="doi">10.1055/a-1578-8778</pub-id>
<pub-id pub-id-type="pmid">34528222</pub-id>
</mixed-citation>
</ref>
<ref id="B53">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Seif</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Aati</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Amer</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ragauskas</surname>
<given-names>A. J.</given-names>
</name>
<name>
<surname>Seif</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>El-Sappah</surname>
<given-names>A. H.</given-names>
</name>
<etal/>
</person-group> (<year>2023</year>). <article-title>Mitigation of hepatotoxicity <italic>via</italic> boosting antioxidants and reducing oxidative stress and inflammation in carbendazim-treated rats using Adiantum capillus-veneris L. extract</article-title>. <source>Molecules</source> <volume>28</volume>, <fpage>4720</fpage>. <pub-id pub-id-type="doi">10.3390/molecules28124720</pub-id>
<pub-id pub-id-type="pmid">37375275</pub-id>
</mixed-citation>
</ref>
<ref id="B54">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sun</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Ge</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>X.</given-names>
</name>
<etal/>
</person-group> (<year>2024a</year>). <article-title>The structure, functions and potential medicinal effects of chlorophylls derived from microalgae</article-title>. <source>Mar. Drugs</source> <volume>22</volume>, <fpage>65</fpage>. <pub-id pub-id-type="doi">10.3390/md22020065</pub-id>
<pub-id pub-id-type="pmid">38393036</pub-id>
</mixed-citation>
</ref>
<ref id="B55">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sun</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Apweiler</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Tirkey</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Klett</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Normann</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Dietz</surname>
<given-names>G. P. H.</given-names>
</name>
<etal/>
</person-group> (<year>2024b</year>). <article-title>Anti-neuroinflammatory effects of Ginkgo biloba extract EGb 761 in LPS-activated BV2 microglial cells</article-title>. <source>Int. J. Mol. Sci.</source> <volume>25</volume>, <fpage>8108</fpage>. <pub-id pub-id-type="doi">10.3390/ijms25158108</pub-id>
<pub-id pub-id-type="pmid">39125680</pub-id>
</mixed-citation>
</ref>
<ref id="B56">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sutterby</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Chheang</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Thurgood</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Khoshmanesh</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Baratchi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Pirogova</surname>
<given-names>E.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Investigating the effects of low intensity visible light on human keratinocytes using a customized LED exposure system</article-title>. <source>Sci. Rep.</source> <volume>12</volume>, <fpage>18907</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-022-23751-3</pub-id>
<pub-id pub-id-type="pmid">36344673</pub-id>
</mixed-citation>
</ref>
<ref id="B57">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tabriz</surname>
<given-names>A. G.</given-names>
</name>
<name>
<surname>Douroumis</surname>
<given-names>D.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Recent advances in 3D printing for wound healing: a systematic review</article-title>. <source>J. Drug Deliv. Sci. Technol.</source> <volume>74</volume>, <fpage>103564</fpage>. <pub-id pub-id-type="doi">10.1016/j.jddst.2022.103564</pub-id>
</mixed-citation>
</ref>
<ref id="B58">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Taniguchi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Lindsey</surname>
<given-names>J. S.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Absorption and fluorescence spectral database of chlorophylls and analogues</article-title>. <source>Photochem. Photobiol.</source> <volume>97</volume>, <fpage>136</fpage>&#x2013;<lpage>165</lpage>. <pub-id pub-id-type="doi">10.1111/php.13319</pub-id>
<pub-id pub-id-type="pmid">32757305</pub-id>
</mixed-citation>
</ref>
<ref id="B59">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tikekar</surname>
<given-names>R. V.</given-names>
</name>
<name>
<surname>Anantheswaran</surname>
<given-names>R. C.</given-names>
</name>
<name>
<surname>Elias</surname>
<given-names>R. J.</given-names>
</name>
<name>
<surname>Laborde</surname>
<given-names>L. F.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Ultraviolet-induced oxidation of ascorbic acid in a model juice system: identification of degradation products</article-title>. <source>J. Agric. Food Chem.</source> <volume>59</volume>, <fpage>8244</fpage>&#x2013;<lpage>8248</lpage>. <pub-id pub-id-type="doi">10.1021/jf201000x</pub-id>
<pub-id pub-id-type="pmid">21699245</pub-id>
</mixed-citation>
</ref>
<ref id="B60">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vallejo</surname>
<given-names>M. C. S.</given-names>
</name>
<name>
<surname>Moura</surname>
<given-names>N. M. M.</given-names>
</name>
<name>
<surname>Faustino</surname>
<given-names>M. A. F.</given-names>
</name>
<name>
<surname>Almeida</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Gon&#xe7;alves</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Serra</surname>
<given-names>V. V.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>An insight into the role of non-porphyrinoid photosensitizers for skin wound healing</article-title>. <source>Int. J. Mol. Sci.</source> <volume>22</volume>, <fpage>234</fpage>. <pub-id pub-id-type="doi">10.3390/ijms22010234</pub-id>
<pub-id pub-id-type="pmid">33379392</pub-id>
</mixed-citation>
</ref>
<ref id="B61">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vichai</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Kirtikara</surname>
<given-names>K.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>Sulforhodamine B colorimetric assay for cytotoxicity screening</article-title>. <source>Nat. Protoc.</source> <volume>13</volume> (<issue>1</issue>), <fpage>1112</fpage>&#x2013;<lpage>1116</lpage>. <pub-id pub-id-type="doi">10.1038/nprot.2006.179</pub-id>
<pub-id pub-id-type="pmid">17406391</pub-id>
</mixed-citation>
</ref>
<ref id="B62">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Progress and trends of photodynamic therapy: from traditional photosensitizers to AIE-based photosensitizers</article-title>. <source>Photodiagnosis Photodyn. Ther.</source> <volume>34</volume>, <fpage>102254</fpage>. <pub-id pub-id-type="doi">10.1016/j.pdpdt.2021.102254</pub-id>
<pub-id pub-id-type="pmid">33713845</pub-id>
</mixed-citation>
</ref>
<ref id="B63">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wilson</surname>
<given-names>J. X.</given-names>
</name>
</person-group> (<year>2002</year>). <article-title>The physiological role of dehydroascorbic acid</article-title>. <source>FEBS Lett.</source> <volume>527</volume>, <fpage>5</fpage>&#x2013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/s0014-5793(02)03167-8</pub-id>
<pub-id pub-id-type="pmid">12220624</pub-id>
</mixed-citation>
</ref>
<ref id="B64">
<mixed-citation publication-type="book">
<collab>World Health Organization (WHO)</collab> (<year>2025</year>). <source>Draft global traditional medicine strategy 2025-2034</source>. <publisher-loc>Geneva, Switzerland</publisher-loc>: <publisher-name>World Health Organization</publisher-name>.</mixed-citation>
</ref>
<ref id="B65">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yazarlu</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Iranshahi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kashani</surname>
<given-names>H. R. K.</given-names>
</name>
<name>
<surname>Reshadat</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Habtemariam</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Iranshahy</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Perspective on the application of medicinal plants and natural products in wound healing: a mechanistic review</article-title>. <source>Pharmacol. Res.</source> <volume>174</volume>, <fpage>105841</fpage>. <pub-id pub-id-type="doi">10.1016/j.phrs.2021.105841</pub-id>
<pub-id pub-id-type="pmid">34419563</pub-id>
</mixed-citation>
</ref>
<ref id="B66">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yuan</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Ruan</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Screening for bioactive compounds from Adiantum capillus-veneris L</article-title>. <source>J. Chem. Soc. Pak.</source> <volume>34</volume>, <fpage>207</fpage>&#x2013;<lpage>216</lpage>. <comment>Available online at: <ext-link ext-link-type="uri" xlink:href="https://jcsp.org.pk/ArticleUpload/3970-19534-1-CE.pdf">https://jcsp.org.pk/ArticleUpload/3970-19534-1-CE.pdf</ext-link>.</comment>
</mixed-citation>
</ref>
<ref id="B67">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yuan</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Xue</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2013</year>). <article-title>Ethanol extract of Adiantum capillus-veneris L. suppresses the production of inflammatory mediators by inhibiting NF-&#x3ba;B activation</article-title>. <source>J. Ethnopharmacol.</source> <volume>147</volume>, <fpage>603</fpage>&#x2013;<lpage>611</lpage>. <pub-id pub-id-type="doi">10.1016/j.jep.2013.03.046</pub-id>
<pub-id pub-id-type="pmid">23542147</pub-id>
</mixed-citation>
</ref>
<ref id="B68">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zeb</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ullah</surname>
<given-names>F.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Reversed phase HPLC-DAD profiling of carotenoids, chlorophylls and phenolic compounds in Adiantum capillus-veneris leaves</article-title>. <source>Front. Chem.</source> <volume>5</volume>, <fpage>29</fpage>. <pub-id pub-id-type="doi">10.3389/fchem.2017.00029</pub-id>
<pub-id pub-id-type="pmid">28497036</pub-id>
</mixed-citation>
</ref>
<ref id="B69">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>Y. W.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Q.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Positive effects of low-dose photodynamic therapy with aminolevulinic acid or its methyl ester in skin rejuvenation and wound healing: an update</article-title>. <source>J. Biophot.</source> <volume>16</volume>, <fpage>e202200293</fpage>. <pub-id pub-id-type="doi">10.1002/jbio.202200293</pub-id>
<pub-id pub-id-type="pmid">36602479</pub-id>
</mixed-citation>
</ref>
</ref-list>
</back>
</article>